RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | bile duct disease |
|
Accession: | DOID:4138
|
browse the term
|
Definition: | A biliary tract disease located_in one or more bile ducts. (DO) |
Synonyms: | exact_synonym: | bile duct diseases; bile duct disorder; disorder of bile duct |
| narrow_synonym: | Non-Neoplastic Bile Duct Disorder |
| primary_id: | MESH:D001649 |
| xref: | EFO:1000400; NCI:C96716 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:21037076 |
RGD:11341737 |
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FECH |
ferrochelatase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10464147 |
|
NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732
|
|
G |
MAGEE1 |
MAGE family member E1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr X:76,427,710...76,431,342
Ensembl chr X:76,427,710...76,431,342
|
|
|
G |
LOC130057954 |
ATAC-STARR-seq lymphoblastoid silent region 6833 |
|
IAGP |
ClinVar Annotator: match by term: Cholestasis-edema syndrome, Norwegian type |
ClinVar |
PMID:25741868 |
|
NCBI chr15:90,935,101...90,935,500
|
|
G |
UNC45A |
unc-45 myosin chaperone A |
|
IAGP |
ClinVar Annotator: match by term: Cholestasis-edema syndrome, Norwegian type |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr15:90,930,180...90,954,093
Ensembl chr15:90,930,180...90,954,093
|
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
|
TAS IAGP ISS EXP ISO |
ClinVar Annotator: match by term: HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC ClinVar Annotator: match by term: Arteriohepatic dysplasia OMIM:118450 | OMIM:610205 CTD Direct Evidence: marker/mechanism DNA:insertion:exon:c.962_963insA (human) |
ClinVar MouseDO CTD RGD |
PMID:9207787 PMID:9207788 PMID:9536098 PMID:9585603 PMID:10220506 PMID:10533065 PMID:11058898 PMID:11139239 PMID:11139247 PMID:11180599 PMID:12497640 PMID:15990638 PMID:16199547 PMID:16575836 PMID:17241866 PMID:17576681 PMID:17949281 PMID:18660822 PMID:19948535 PMID:20437614 PMID:21532573 PMID:21752016 PMID:22040217 PMID:22405927 PMID:22487239 PMID:22488849 PMID:22759690 PMID:23891399 PMID:23956173 PMID:24033266 PMID:24748328 PMID:25260786 PMID:25676721 PMID:25741868 PMID:26076142 PMID:26760175 PMID:27256232 PMID:28492532 PMID:29187043 PMID:29483232 PMID:30074189 PMID:31343788 PMID:31475041 PMID:34071626 PMID:34150014 PMID:34185059 PMID:34399559 PMID:34746741 PMID:36973604 PMID:37600608 PMID:11745040 PMID:16875832 PMID:21714972 More...
|
RGD:1580651, RGD:6482237, RGD:6482232 |
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
|
|
G |
NOTCH2 |
notch receptor 2 |
|
IAGP EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16773578 |
RGD:1580762 |
NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779
|
|
|
G |
ANKEF1 |
ankyrin repeat and EF-hand domain containing 1 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:10,034,987...10,058,303
Ensembl chr20:9,986,126...10,058,303
|
|
G |
HAO1 |
hydroxyacid oxidase 1 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:7,882,985...7,940,458
Ensembl chr20:7,882,985...7,940,458
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome 1 ClinVar Annotator: match by term: Alagille syndrome 1 | ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar OMIM |
PMID:9207787 PMID:9207788 PMID:9536098 PMID:9585603 PMID:9700188 PMID:10213047 PMID:10220506 PMID:10533065 PMID:11058898 PMID:11139239 PMID:11139247 PMID:11152664 PMID:11157803 PMID:11180599 PMID:11181574 PMID:11259677 PMID:12022040 PMID:12239725 PMID:12244555 PMID:12442286 PMID:12497640 PMID:12649809 PMID:15358557 PMID:15712272 PMID:15772854 PMID:15990638 PMID:16199547 PMID:16575836 PMID:16875832 PMID:17241866 PMID:17576681 PMID:17720887 PMID:17949281 PMID:18660822 PMID:19058200 PMID:19780835 PMID:19948535 PMID:20301450 PMID:20437614 PMID:21752016 PMID:22040217 PMID:22382802 PMID:22405927 PMID:22487239 PMID:22488849 PMID:22759690 PMID:23891399 PMID:23956173 PMID:24033266 PMID:24684524 PMID:24748328 PMID:25260786 PMID:25525159 PMID:25606387 PMID:25676721 PMID:25741868 PMID:26076142 PMID:26548814 PMID:26633542 PMID:26760175 PMID:26785492 PMID:27256232 PMID:27760138 PMID:28492532 PMID:28695677 PMID:29187043 PMID:29453956 PMID:29483232 PMID:29555955 PMID:29707407 PMID:29783821 PMID:30074189 PMID:30293987 PMID:31343788 PMID:31475041 PMID:31595668 PMID:32065591 PMID:32733715 PMID:33433009 PMID:33532864 PMID:34071626 PMID:34150014 PMID:34185059 PMID:34399559 PMID:34746741 PMID:36474027 PMID:36973604 PMID:37600608 More...
|
|
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
|
|
G |
LAMP5 |
lysosomal associated membrane protein family member 5 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:9,514,590...9,530,524
Ensembl chr20:9,514,358...9,530,524
|
|
G |
LOC112694687 |
Sharpr-MPRA regulatory region 2397 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,511,421...10,511,935
|
|
G |
LOC112694688 |
Sharpr-MPRA regulatory region 11569 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,592,961...10,593,255
|
|
G |
LOC121627892 |
Sharpr-MPRA regulatory region 8388 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,523,941...10,524,235
|
|
G |
LOC125384578 |
Sharpr-MPRA regulatory region 5326 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,527,841...10,528,135
|
|
G |
LOC125384579 |
Sharpr-MPRA regulatory region 6934 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,578,601...10,578,895
|
|
G |
LOC125384580 |
Sharpr-MPRA regulatory region 15707 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,651,181...10,651,475
|
|
G |
LOC126862972 |
P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:10399946-10401145 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,419,298...10,420,497
|
|
G |
LOC126862973 |
CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:10578661-10579860 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,598,013...10,599,212
|
|
G |
LOC128706665 |
uncharacterized LOC128706665 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,413,708...10,434,222
|
|
G |
LOC128706666 |
uncharacterized LOC128706666 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,413,708...10,434,222
|
|
G |
LOC130065416 |
ATAC-STARR-seq lymphoblastoid active region 17541 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,350,866...10,351,095
|
|
G |
LOC130065417 |
ATAC-STARR-seq lymphoblastoid silent region 12671 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,428,263...10,428,312
|
|
G |
LOC130065418 |
ATAC-STARR-seq lymphoblastoid active region 17542 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,434,069...10,434,128
|
|
G |
LOC130065419 |
ATAC-STARR-seq lymphoblastoid active region 17543 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,435,019...10,435,248
|
|
G |
LOC130065420 |
ATAC-STARR-seq lymphoblastoid active region 17544 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,435,409...10,435,458
|
|
G |
LOC130065421 |
ATAC-STARR-seq lymphoblastoid active region 17545 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,507,204...10,507,343
|
|
G |
LOC130065422 |
ATAC-STARR-seq lymphoblastoid active region 17547 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,558,743...10,559,122
|
|
G |
LOC130065423 |
ATAC-STARR-seq lymphoblastoid silent region 12672 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,647,667...10,647,716
|
|
G |
LOC130065424 |
ATAC-STARR-seq lymphoblastoid silent region 12673 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,670,642...10,670,691
|
|
G |
LOC130065425 |
ATAC-STARR-seq lymphoblastoid silent region 12674 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:28492532 |
|
NCBI chr20:10,670,742...10,670,791
|
|
G |
MIR6870 |
microRNA 6870 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:16575836 PMID:19058200 PMID:22382802 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr20:10,649,636...10,649,695
Ensembl chr20:10,649,636...10,649,695
|
|
G |
MKKS |
MKKS centrosomal shuttling protein |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:10,401,009...10,434,222
Ensembl chr20:10,401,009...10,434,222
|
|
G |
PAK5 |
p21 (RAC1) activated kinase 5 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:9,537,370...9,839,076
Ensembl chr20:9,537,370...9,839,076
|
|
G |
PLCB1 |
phospholipase C beta 1 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360
|
|
G |
PLCB4 |
phospholipase C beta 4 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
|
|
G |
SLX4IP |
SLX4 interacting protein |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:10,435,305...10,628,030
Ensembl chr20:10,435,305...10,636,829
|
|
G |
SNAP25 |
synaptosome associated protein 25 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258
|
|
G |
TMX4 |
thioredoxin related transmembrane protein 4 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chr20:7,977,346...8,019,761
Ensembl chr20:7,977,346...8,019,805
|
|
|
G |
NOTCH2 |
notch receptor 2 |
|
IAGP |
ClinVar Annotator: match by term: Alagille syndrome 2 |
ClinVar OMIM |
PMID:16773578 PMID:21378985 PMID:23389697 PMID:24728327 PMID:25016221 PMID:25741868 PMID:26627824 PMID:28492532 PMID:28512196 PMID:28566479 PMID:28776642 PMID:28941602 PMID:29698804 PMID:30143558 PMID:31749841 PMID:32164334 PMID:32368696 More...
|
|
NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779
|
|
|
G |
VIPAS39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
EXP IAGP ISS |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Arthrogryposis with renal dysfunction and cholestasis syndrome |
CTD ClinVar MouseDO |
PMID:20190753 PMID:25741868 |
|
NCBI chr14:77,426,675...77,457,601
Ensembl chr14:77,426,675...77,457,952
|
|
G |
VPS33B |
VPS33B late endosome and lysosome associated |
|
EXP ISS IAGP |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Arthrogryposis with renal dysfunction and cholestasis syndrome |
CTD MouseDO ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr15:90,998,416...91,022,621
Ensembl chr15:90,998,673...91,022,603
|
|
|
G |
FBN1 |
fibrillin 1 |
|
IAGP |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
ClinVar |
PMID:25741868 |
|
NCBI chr15:48,408,313...48,645,709
Ensembl chr15:48,408,313...48,645,721
|
|
G |
VIPAS39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
IAGP |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
ClinVar |
PMID:25741868 PMID:31319225 |
|
NCBI chr14:77,426,675...77,457,601
Ensembl chr14:77,426,675...77,457,952
|
|
G |
VPS33B |
VPS33B late endosome and lysosome associated |
|
IAGP |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
OMIM ClinVar |
PMID:8151641 PMID:9536098 PMID:11668108 PMID:15052268 PMID:16896922 PMID:17576681 PMID:17994566 PMID:18853461 PMID:19274792 PMID:21851503 PMID:22753090 PMID:24782640 PMID:24917129 PMID:25741868 PMID:26505894 PMID:28492532 PMID:29907094 PMID:31343487 PMID:31479177 More...
|
|
NCBI chr15:90,998,416...91,022,621
Ensembl chr15:90,998,673...91,022,603
|
|
|
G |
VIPAS39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
IAGP |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 2 |
OMIM ClinVar |
PMID:20190753 PMID:25741868 PMID:28492532 PMID:31479177 |
|
NCBI chr14:77,426,675...77,457,601
Ensembl chr14:77,426,675...77,457,952
|
|
|
G |
ATP8B1 |
ATPase phospholipid transporting 8B1 |
|
IAGP |
ClinVar Annotator: match by term: Summerskill syndrome DNA:missense mutation:cds:p.I661T (human) |
ClinVar OMIM RGD |
PMID:5807632 PMID:7894490 PMID:9500542 PMID:9918928 PMID:11815775 PMID:14988830 PMID:15239083 PMID:15317749 PMID:15657619 PMID:15888793 PMID:15975683 PMID:16199547 PMID:17592371 PMID:19260995 PMID:19731236 PMID:19918981 PMID:20232290 PMID:20414253 PMID:20981092 PMID:22525741 PMID:22995991 PMID:24033266 PMID:24260417 PMID:25421123 PMID:25737299 PMID:25741868 PMID:26126923 PMID:26382629 PMID:26678486 PMID:26858187 PMID:26879107 PMID:27050426 PMID:27530795 PMID:28492532 PMID:28733223 PMID:28924228 PMID:29238877 PMID:30366773 PMID:31450232 PMID:32650689 PMID:32695736 PMID:32942997 PMID:33437900 PMID:33666275 PMID:34016879 PMID:35416773 PMID:35431768 PMID:35894240 PMID:9918928 More...
|
RGD:14401576 |
NCBI chr18:57,646,426...57,803,315
Ensembl chr18:57,646,426...57,803,315
|
|
G |
ATP8B1-AS1 |
ATP8B1 antisense RNA 1 |
|
IAGP |
ClinVar Annotator: match by term: Summerskill syndrome |
ClinVar |
PMID:7894490 PMID:9500542 PMID:15239083 PMID:16199547 PMID:17592371 PMID:22525741 PMID:25421123 PMID:25737299 PMID:25741868 PMID:26126923 PMID:27050426 PMID:28492532 PMID:28733223 PMID:30366773 PMID:31450232 PMID:33666275 PMID:34016879 PMID:35431768 More...
|
|
NCBI chr18:57,630,331...57,669,283
Ensembl chr18:57,629,870...57,738,678
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
|
IAGP |
ClinVar Annotator: match by term: Benign recurrent intrahepatic cholestasis type 2 |
OMIM ClinVar |
PMID:9536098 PMID:9806540 PMID:10579978 PMID:12370274 PMID:12717091 PMID:14672610 PMID:15300568 PMID:15317749 PMID:15791618 PMID:16039748 PMID:16199547 PMID:16290310 PMID:16641580 PMID:16868810 PMID:16871584 PMID:17241866 PMID:17576681 PMID:17855769 PMID:17947449 PMID:18395098 PMID:18692205 PMID:18798335 PMID:19101985 PMID:19750581 PMID:19845854 PMID:20232290 PMID:20414253 PMID:20583290 PMID:20683201 PMID:21404481 PMID:21490445 PMID:22364601 PMID:22609309 PMID:22795478 PMID:23022423 PMID:23279303 PMID:23437912 PMID:23750872 PMID:24115678 PMID:24231640 PMID:24339557 PMID:24402531 PMID:24530123 PMID:24627769 PMID:24711118 PMID:24969679 PMID:24991443 PMID:25716872 PMID:25741868 PMID:25771912 PMID:25847299 PMID:26019043 PMID:26126923 PMID:26382629 PMID:26678486 PMID:26858187 PMID:27050426 PMID:27114171 PMID:27153395 PMID:27239116 PMID:27368585 PMID:27426735 PMID:28027573 PMID:28119944 PMID:28425419 PMID:28454995 PMID:28492532 PMID:28733223 PMID:28776642 PMID:29104077 PMID:29316097 PMID:29404523 PMID:29412511 PMID:29625052 PMID:29992621 PMID:30210030 PMID:30366773 PMID:31015375 PMID:31091858 PMID:31450232 PMID:31538484 PMID:31745229 PMID:32087350 PMID:32309332 PMID:32581362 PMID:32793533 PMID:32808743 PMID:32860008 PMID:32917322 PMID:32942997 PMID:33201677 PMID:33215027 PMID:33915153 PMID:34008892 PMID:34016879 PMID:34942279 PMID:35257483 PMID:35780807 PMID:37471416 More...
|
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
LOC126806400 |
CDK7 strongly-dependent group 2 enhancer GRCh37_chr2:169791870-169793069 |
|
IAGP |
ClinVar Annotator: match by term: Benign recurrent intrahepatic cholestasis type 2 |
ClinVar |
PMID:16039748 PMID:17241866 PMID:18395098 PMID:19101985 PMID:20232290 PMID:20414253 PMID:20683201 PMID:23279303 PMID:24115678 PMID:25741868 PMID:26382629 PMID:26678486 PMID:27368585 PMID:28492532 More...
|
|
NCBI chr 2:168,935,360...168,936,559
|
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
disease_progression |
IEP |
|
RGD |
PMID:24131658 |
RGD:151361287 |
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507
|
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
|
IAGP |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:25704541 |
RGD:11521169 |
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
|
G |
APOB |
apolipoprotein B |
susceptibility |
IAGP |
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
|
|
G |
APOE |
apolipoprotein E |
susceptibility |
IAGP |
DNA:SNP:intron:rs440446 (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
|
|
G |
ATM |
ATM serine/threonine kinase |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
|
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
MIR31 |
microRNA 31 |
exacerbates |
IEP |
RNA:increased expression:bile duct (human) |
RGD |
PMID:29860474 |
RGD:152998990 |
NCBI chr 9:21,512,115...21,512,185
Ensembl chr 9:21,512,115...21,512,185
|
|
G |
MLH1 |
mutL homolog 1 |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25157968 PMID:25741868 PMID:25823662 PMID:28492532 More...
|
|
NCBI chr 3:36,993,466...37,050,846
Ensembl chr 3:36,993,226...37,050,896
|
|
G |
MSH2 |
mutS homolog 2 |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:33357406 |
|
NCBI chr 2:47,403,067...47,709,830
Ensembl chr 2:47,403,067...47,663,146
|
|
G |
PALB2 |
partner and localizer of BRCA2 |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823 |
|
NCBI chr16:23,603,165...23,641,310
Ensembl chr16:23,603,160...23,641,321
|
|
G |
PKD1 |
polycystin 1, transient receptor potential channel interacting |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
|
|
NCBI chr16:2,088,708...2,135,898
Ensembl chr16:2,088,708...2,135,898
|
|
G |
POLD1 |
DNA polymerase delta 1, catalytic subunit |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chr19:50,384,323...50,418,018
Ensembl chr19:50,384,204...50,418,018
|
|
G |
STK11 |
serine/threonine kinase 11 |
|
IAGP |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
|
|
G |
TJP1 |
tight junction protein 1 |
|
IEP |
protein:decreased expression:bile duct |
RGD |
PMID:19184677 |
RGD:2325030 |
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
|
G |
MSLN |
mesothelin |
|
IEP |
protein:increased expression:bile duct |
RGD |
PMID:17276942 |
RGD:2326059 |
NCBI chr16:760,734...768,865
Ensembl chr16:760,734...768,865
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
disease_progression |
IEP |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507
|
|
|
G |
ASPH |
aspartate beta-hydroxylase |
|
IEP |
mRNA:increased expression:bile duct |
RGD |
PMID:16673309 |
RGD:2325824 |
NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
|
|
G |
EGFR |
epidermal growth factor receptor |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17341899 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
FSCN1 |
fascin actin-bundling protein 1 |
disease_progression |
IEP |
protein:increased expression:bile duct |
RGD |
PMID:17419223 |
RGD:2317786 |
NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655
|
|
G |
IL6 |
interleukin 6 |
disease_progression |
IEP |
protein:increased expression:serum |
RGD |
PMID:17617204 |
RGD:2317166 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
IEP |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15892172 |
RGD:2317585 |
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
|
|
G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
severity |
IEP |
protein:decreased expression:carcinoma of extrahepatic bile duct (human) |
RGD |
PMID:11986189 |
RGD:2317662 |
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
disease_progression |
IEP |
|
RGD |
PMID:9869516 |
RGD:2317706 |
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MUC16 |
mucin 16, cell surface associated |
|
IEP |
protein:increased expression:serum,bile |
RGD |
PMID:1657243 |
RGD:2325134 |
NCBI chr19:8,848,844...9,065,751
Ensembl chr19:8,848,844...9,010,390
|
|
G |
MUC4 |
mucin 4, cell surface associated |
disease_progression |
IEP |
protein:increased expression:bile duct |
RGD |
PMID:16857800 |
RGD:2324929 |
NCBI chr 3:195,746,771...195,811,929
Ensembl chr 3:195,746,765...195,811,973
|
|
G |
NCAM1 |
neural cell adhesion molecule 1 |
disease_progression |
IEP IDA |
|
RGD |
PMID:8501910 PMID:9851639 |
RGD:2326077, RGD:2326076 |
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
|
|
G |
RUNX3 |
RUNX family transcription factor 3 |
|
IDA |
DNA:hypermethylation:promoter |
RGD |
PMID:15471559 |
RGD:2324957 |
NCBI chr 1:24,899,511...24,965,138
Ensembl chr 1:24,899,511...24,965,121
|
|
G |
ZNF667-AS1 |
ZNF667 antisense RNA 1 (head to head) |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29707199 |
|
NCBI chr19:56,477,874...56,495,437
Ensembl chr19:56,477,250...56,504,362
|
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21356120 |
RGD:5686894 |
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
CD14 |
CD14 molecule |
disease_progression |
IEP |
mRNA, protein:increased expression:liver, plasma: |
RGD |
PMID:21172039 |
RGD:7184431 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
IEP |
protein:increased expression:serum (human) |
RGD |
PMID:24493287 |
RGD:26884361 |
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
DLK1 |
delta like non-canonical Notch ligand 1 |
|
IEP |
|
RGD |
PMID:14743499 |
RGD:1625622 |
NCBI chr14:100,726,892...100,738,224
Ensembl chr14:100,725,705...100,738,224
|
|
G |
GGT1 |
gamma-glutamyltransferase 1 |
disease_progression |
IEP |
|
RGD |
PMID:29056230 |
RGD:14701039 |
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
|
|
G |
GLI2 |
GLI family zinc finger 2 |
disease_progression |
IEP |
|
RGD |
PMID:25746691 |
RGD:12802349 |
NCBI chr 2:120,735,868...120,992,653
Ensembl chr 2:120,735,623...120,992,653
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16627878 |
|
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
susceptibility |
IAGP |
DNA:missense mutation:cds:p.G241R (human) |
RGD |
PMID:18401716 |
RGD:14402043 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL18 |
interleukin 18 |
susceptibility |
IAGP IEP |
DNA:SNPs, haplotype:promoter:rs187238,rs1946518(human) protein:increased expression:serum: |
RGD |
PMID:30059753 PMID:10726686 |
RGD:14695528, RGD:14695529 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
MIR145 |
microRNA 145 |
|
IEP |
miRNA:decreased expression:liver (human) |
RGD |
PMID:28902846 |
RGD:15039396 |
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
|
|
G |
MIR155 |
microRNA 155 |
|
IEP |
miRNA:increased expression:liver |
RGD |
PMID:28355202 PMID:27817193 |
RGD:24922206, RGD:25671379 |
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
|
|
G |
PTEN |
phosphatase and tensin homolog |
|
IEP |
mRNA:decreased expression:liver (human) |
RGD |
PMID:25487473 |
RGD:12832754 |
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
SHH |
sonic hedgehog signaling molecule |
disease_progression |
IEP |
|
RGD |
PMID:25746691 |
RGD:12802349 |
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
|
|
G |
SOX17 |
SRY-box transcription factor 17 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892
|
|
G |
SPINT1 |
serine peptidase inhibitor, Kunitz type 1 |
disease_progression |
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chr15:40,844,048...40,858,207
Ensembl chr15:40,844,018...40,858,207
|
|
G |
SPINT2 |
serine peptidase inhibitor, Kunitz type 2 |
|
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chr19:38,264,573...38,292,615
Ensembl chr19:38,244,035...38,292,615
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
|
IDA |
|
RGD |
PMID:15845635 |
RGD:1581370 |
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
treatment |
IEP |
|
RGD |
PMID:30686515 |
RGD:14985228 |
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
|
G |
ANGPT2 |
angiopoietin 2 |
|
ISO |
protein:increased expression:bile duct (rat) |
RGD |
PMID:16628643 |
RGD:2314213 |
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
|
|
G |
IFT56 |
intraflagellar transport 56 |
|
IAGP |
ClinVar Annotator: match by term: Caroli disease |
ClinVar |
PMID:25741868 PMID:31595528 PMID:32617964 |
|
NCBI chr 7:139,133,778...139,191,986
Ensembl chr 7:139,133,744...139,191,986
|
|
G |
LOC126859690 |
MED14-independent group 3 enhancer GRCh37_chr6:51888848-51890047 |
|
IAGP |
ClinVar Annotator: match by term: Caroli disease |
ClinVar |
PMID:1189128 PMID:11898128 PMID:12874454 PMID:15805161 PMID:16133180 PMID:19914852 PMID:20413436 PMID:25701400 PMID:25741868 PMID:26695994 PMID:27151922 PMID:27225849 PMID:27894351 PMID:28492532 PMID:29068549 PMID:31130284 PMID:31844813 PMID:31980526 PMID:32398770 PMID:32571524 PMID:32574212 PMID:32799815 More...
|
|
NCBI chr 6:52,024,050...52,025,249
|
|
G |
PKHD1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
IAGP |
ClinVar Annotator: match by term: Caroli disease |
ClinVar |
PMID:1189128 PMID:11898128 PMID:12846734 PMID:12874454 PMID:15108277 PMID:15108281 PMID:15698423 PMID:15805161 PMID:16133180 PMID:19914852 PMID:20413436 PMID:21228398 PMID:25701400 PMID:25741868 PMID:26695994 PMID:27151922 PMID:27225849 PMID:27894351 PMID:28492530 PMID:28492532 PMID:29068549 PMID:30343465 PMID:30773290 PMID:31130284 PMID:31844813 PMID:31980526 PMID:32359821 PMID:32398770 PMID:32571524 PMID:32574212 PMID:32799815 PMID:35715958 More...
|
|
NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613
|
|
G |
WDR19 |
WD repeat domain 19 |
|
IAGP |
associated with Nephronophthisis 13;DNA:missense mutations:cds:multiple (human) |
RGD |
PMID:25726036 |
RGD:11528287 |
NCBI chr 4:39,182,529...39,285,810
Ensembl chr 4:39,182,504...39,285,810
|
|
|
G |
PKHD1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISS |
|
MouseDO |
|
|
NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613
|
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
IAGP |
DNA:polymorphism:exon:c.3972C>T (human) |
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
ALB |
albumin |
disease_progression |
IEP IDA |
|
RGD |
PMID:20431764 PMID:10776430 PMID:17545000 |
RGD:2325679, RGD:2325682, RGD:2325680 |
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
IEP |
protein:increased expression:bile duct |
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ANXA2 |
annexin A2 |
disease_progression |
IEP |
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
|
|
G |
ANXA8 |
annexin A8 |
|
IEP |
|
RGD |
PMID:19376120 |
RGD:2325733 |
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
|
|
G |
APC |
APC regulator of WNT signaling pathway |
|
IDA IAGP |
DNA:hypermethylation:promoter DNA:loss of heterozygosity |
RGD |
PMID:15467712 PMID:10212000 |
RGD:2317198, RGD:2317205 |
NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239
|
|
G |
APOA1 |
apolipoprotein A1 |
|
IEP |
protein:decreased expression:serum |
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622
|
|
G |
ARID1A |
AT-rich interaction domain 1A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 1:26,696,015...26,782,104
Ensembl chr 1:26,693,236...26,782,104
|
|
G |
ASPH |
aspartate beta-hydroxylase |
|
IDA |
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
|
|
G |
ATG101 |
autophagy related 101 |
disease_progression |
IEP |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chr12:52,065,300...52,077,495
Ensembl chr12:52,069,246...52,077,495
|
|
G |
BAP1 |
BRCA1 associated deubiquitinase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
|
|
G |
BIRC6 |
baculoviral IAP repeat containing 6 |
ameliorates |
HEP |
mRNA:increased expression:bile duct (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 2:32,357,023...32,618,878
Ensembl chr 2:32,357,023...32,619,571
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
|
IAGP |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
onset |
IEP |
protein:decreased expression:liver |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
|
|
G |
CST1 |
cystatin SN |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr20:23,747,562...23,750,935
Ensembl chr20:23,747,562...23,751,268
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR1 |
C-X-C motif chemokine receptor 1 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962
|
|
G |
CYCS |
cytochrome c, somatic |
|
IDA |
|
RGD |
PMID:19788692 |
RGD:2317615 |
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP24A1 |
cytochrome P450 family 24 subfamily A member 1 |
|
HEP |
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human) |
RGD |
PMID:23375797 |
RGD:151361187 |
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
|
|
G |
EGF |
epidermal growth factor |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:25741868 PMID:28492532 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
|
EXP IAGP |
CTD Direct Evidence: therapeutic ClinVar Annotator: match by term: Cholangiocarcinoma |
CTD ClinVar |
PMID:17341899 PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EPO |
erythropoietin |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
EPOR |
erythropoietin receptor |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
|
|
G |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 |
|
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
|
|
G |
EZH2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression no_association |
IAGP |
DNA:SNP: :g.148505302C>T (rs887569) (human) DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) |
RGD |
PMID:24179546 PMID:24179546 |
RGD:126779604, RGD:126779604 |
NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
|
|
G |
FAM66C |
family with sequence similarity 66 member C |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chr12:8,180,209...8,201,000
Ensembl chr12:8,180,204...8,226,278
|
|
G |
FASLG |
Fas ligand |
|
IDA |
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FGF2 |
fibroblast growth factor 2 |
|
IEP |
protein:increased expression:bile |
RGD |
PMID:11478488 |
RGD:2317765 |
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
FGFR2 |
fibroblast growth factor receptor 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
|
|
G |
FSCN1 |
fascin actin-bundling protein 1 |
disease_progression |
IEP |
protein:increased expression:bile ducts |
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655
|
|
G |
GNAS |
GNAS complex locus |
disease_progression |
IAGP EXP |
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22561520 PMID:17356712 |
RGD:1601377 |
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
|
IAGP |
|
RGD |
PMID:24049014 |
RGD:14700980 |
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
treatment |
IDA IMP |
DNA:hypermethylation:promoter human cell line in a mouse model |
RGD |
PMID:15467712 PMID:12805482 |
RGD:2317198, RGD:14401711 |
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
HDAC6 |
histone deacetylase 6 |
|
IEP |
protein:increased expression:liver: |
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chr X:48,801,398...48,824,982
Ensembl chr X:48,801,377...48,824,982
|
|
G |
HGF |
hepatocyte growth factor |
|
ISO IEP |
mRNA, protein:increased expression: : protein:increased expression:serum |
RGD |
PMID:10827151 PMID:16974053 |
RGD:2317925, RGD:2317909 |
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HIF1A-AS3 |
HIF1A antisense RNA 3 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chr14:61,715,558...61,751,097
Ensembl chr14:61,678,402...61,751,163
|
|
G |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
|
|
G |
IDH2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
|
|
G |
IL10 |
interleukin 10 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL19 |
interleukin 19 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr 1:206,770,773...206,842,981
Ensembl chr 1:206,770,764...206,842,981
|
|
G |
IL1B |
interleukin 1 beta |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1R2 |
interleukin 1 receptor type 2 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
|
|
G |
IL4R |
interleukin 4 receptor |
|
IEP |
mRNA:increased expression:bile duct |
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
|
|
G |
IL6 |
interleukin 6 |
|
IEP IAGP EXP |
ClinVar Annotator: match by term: Cholangiocarcinoma protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17621267 PMID:17623760 PMID:18550579 PMID:15011822 PMID:28925763 More...
|
RGD:2317167, RGD:14975292 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL6-AS1 |
IL6 antisense RNA 1 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
|
|
NCBI chr 7:22,725,395...22,727,620
Ensembl chr 7:22,725,395...22,727,620
|
|
G |
INS |
insulin |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
KCND2 |
potassium voltage-gated channel subfamily D member 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
|
|
G |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
|
|
G |
KMT2C |
lysine methyltransferase 2C |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr 7:152,134,925...152,436,003
Ensembl chr 7:152,134,922...152,436,644
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
KRT7 |
keratin 7 |
|
IEP |
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
|
|
G |
LOC126859963 |
BRD4-independent group 4 enhancer GRCh37_chr7:22766269-22767468 |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
|
|
NCBI chr 7:22,726,650...22,727,849
|
|
G |
MDM2 |
MDM2 proto-oncogene |
disease_progression |
IEP |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MET |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
IEP ISO |
protein:increased phosphorylation:liver, carcinoma (human) protein:increased expression:liver, biliary epithelium (rat) |
RGD |
PMID:16818635 PMID:14656942 |
RGD:2317578, RGD:2317601 |
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
|
|
G |
MFSD4A |
major facilitator superfamily domain containing 4A |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 1:205,569,014...205,602,918
Ensembl chr 1:205,568,885...205,602,918
|
|
G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
IAGP |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
|
|
G |
MIR155 |
microRNA 155 |
|
IEP |
miRNA:increased expression:serum |
RGD |
PMID:30653586 |
RGD:21081530 |
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
|
|
G |
MIR192 |
microRNA 192 |
|
IEP |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr11:64,891,137...64,891,246
Ensembl chr11:64,891,137...64,891,246
|
|
G |
MIR21 |
microRNA 21 |
|
IEP |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR23B |
microRNA 23b |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304
|
|
G |
MIR494 |
microRNA 494 |
severity exacerbates |
IEP IMP |
|
RGD |
PMID:30314946 PMID:30314946 |
RGD:156420141, RGD:156420141 |
NCBI chr14:101,029,634...101,029,714
Ensembl chr14:101,029,634...101,029,714
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
disease_progression |
IEP |
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
disease_progression |
ISO IEP |
protein:increased expression:bile duct |
RGD |
PMID:15213623 PMID:19629755 |
RGD:2324667, RGD:2325769 |
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
IEP ISO |
mRNA:increased expression:bile duct protein:increased expression:bile duct |
RGD |
PMID:16463672 PMID:15213623 PMID:15213623 |
RGD:2325856, RGD:2324667, RGD:2324667 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MSLN |
mesothelin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14576474 |
|
NCBI chr16:760,734...768,865
Ensembl chr16:760,734...768,865
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
susceptibility |
IAGP |
DNA:polymorphism (human) |
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
|
|
G |
MUC1 |
mucin 1, cell surface associated |
disease_progression |
IEP ISO |
mRNA:increased expression:bile duct protein:increased expression:bile duct: protein:increased expression:serum protein:increased secretion:bile |
RGD |
PMID:19639217 PMID:18081149 PMID:15213623 PMID:19260467 PMID:19055478 |
RGD:2317986, RGD:2324638, RGD:2324667, RGD:2324664, RGD:2324622 |
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
|
|
G |
MUC16 |
mucin 16, cell surface associated |
|
IEP |
associated with Opisthorchiasis;protein:increased expression:serum |
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chr19:8,848,844...9,065,751
Ensembl chr19:8,848,844...9,010,390
|
|
G |
MUC2 |
mucin 2, oligomeric mucus/gel-forming |
|
IEP |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511
|
|
G |
MUC3A |
mucin 3A, cell surface associated |
|
IEP |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr 7:100,949,534...100,968,347
Ensembl chr 7:100,949,534...100,968,347
|
|
G |
MUC4 |
mucin 4, cell surface associated |
disease_progression |
IEP ISO |
protein:increased expression:bile duct |
RGD |
PMID:14752841 PMID:19082442 |
RGD:2324944, RGD:2303602 |
NCBI chr 3:195,746,771...195,811,929
Ensembl chr 3:195,746,765...195,811,973
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
disease_progression |
IEP |
protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:14508831 PMID:11680592 |
RGD:2324990, RGD:2324948 |
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
IEP |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
|
|
G |
MUC6 |
mucin 6, oligomeric mucus/gel-forming (gene/pseudogene) |
|
IEP |
protein:increased expression: : |
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chr11:1,012,823...1,036,718
Ensembl chr11:1,012,823...1,036,718
|
|
G |
NAT2 |
N-acetyltransferase 2 |
|
IAGP |
DNA:polymorphisms (human) |
RGD |
PMID:15901993 |
RGD:2317172 |
NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
|
|
G |
NCAM1 |
neural cell adhesion molecule 1 |
|
IEP |
associated with hepatitis |
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
IEP EXP |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16818635 PMID:16094703 |
RGD:2325280 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOTCH1 |
notch receptor 1 |
|
IEP |
protein:increased expression:cholangiocyte |
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
OGG1 |
8-oxoguanine DNA glycosylase |
disease_progression |
IAGP |
DNA:loss of heterozygosity (human) |
RGD |
PMID:11866974 PMID:11260864 |
RGD:2317134, RGD:2317136 |
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
|
|
G |
OSBP2 |
oxysterol binding protein 2 |
|
IEP |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chr22:30,693,782...30,907,813
Ensembl chr22:30,693,782...30,907,824
|
|
G |
OSBPL7 |
oxysterol binding protein like 7 |
|
IEP |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chr17:47,807,372...47,821,794
Ensembl chr17:47,807,372...47,821,803
|
|
G |
PACERR |
PTGS2 antisense NFKB1 complex-mediated expression regulator RNA |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
|
|
NCBI chr 1:186,680,654...186,681,446
Ensembl chr 1:186,680,108...186,683,165
|
|
G |
PANX2 |
pannexin 2 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr22:50,170,731...50,180,295
Ensembl chr22:50,170,731...50,180,295
|
|
G |
PAWR |
pro-apoptotic WT1 regulator |
|
IEP |
mRNA,protein:decreased expression:cholangiocyte: |
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964
|
|
G |
PBRM1 |
polybromo 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 3:52,545,367...52,685,913
Ensembl chr 3:52,545,352...52,685,917
|
|
G |
PEG3 |
paternally expressed 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr19:56,810,082...56,840,726
Ensembl chr19:56,810,077...56,840,728
|
|
G |
PES1 |
pescadillo ribosomal biogenesis factor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34845814 |
|
NCBI chr22:30,576,625...30,607,013
Ensembl chr22:30,576,625...30,607,083
|
|
G |
PIR |
pirin |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
|
|
G |
PPIA |
peptidylprolyl isomerase A |
ameliorates |
IMP |
human cell line and construct in a mouse model |
RGD |
PMID:21871105 |
RGD:150429623 |
NCBI chr 7:44,796,681...44,803,117
Ensembl chr 7:44,796,680...44,824,564
|
|
G |
PPP3CA |
protein phosphatase 3 catalytic subunit alpha |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278
|
|
G |
PREX2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
IAGP |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:28000796 |
RGD:151665188 |
NCBI chr 8:67,952,046...68,237,032
Ensembl chr 8:67,952,046...68,237,032
|
|
G |
PRKACA |
protein kinase cAMP-activated catalytic subunit alpha |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084
|
|
G |
PRKACB |
protein kinase cAMP-activated catalytic subunit beta |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr 1:84,078,079...84,238,498
Ensembl chr 1:84,078,062...84,238,498
|
|
G |
PRRG4 |
proline rich and Gla domain 4 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr11:32,829,789...32,858,120
Ensembl chr11:32,829,927...32,858,120
|
|
G |
PRSS2 |
serine protease 2 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:8621252 |
RGD:2324908 |
NCBI chr 7:142,770,970...142,774,560
Ensembl chr 7:142,760,398...142,774,564
|
|
G |
PRSS56 |
serine protease 56 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 2:232,520,388...232,525,716
Ensembl chr 2:232,520,388...232,525,716
|
|
G |
PTEN |
phosphatase and tensin homolog |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27022031 PMID:23376645 |
RGD:12802341 |
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
IEP IAGP EXP |
protein:increased expression:bile duct ClinVar Annotator: match by term: Cholangiocarcinoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:16818635 PMID:19621664 |
RGD:2317180 |
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RASSF8 |
Ras association domain family member 8 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr12:25,958,232...26,079,889
Ensembl chr12:25,958,232...26,079,892
|
|
G |
REG1A |
regenerating family member 1 alpha |
susceptibility |
IEP |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:11343228 |
RGD:10044031 |
NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409
|
|
G |
RNF39 |
ring finger protein 39 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 6:30,070,270...30,075,769
Ensembl chr 6:30,070,266...30,075,849
|
|
G |
RNF43 |
ring finger protein 43 |
exacerbates |
EXP IAGP |
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human) |
CTD RGD |
PMID:22561520 PMID:22561520 |
RGD:151361227 |
NCBI chr17:58,352,500...58,417,534
Ensembl chr17:58,353,676...58,417,595
|
|
G |
ROBO2 |
roundabout guidance receptor 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr 3:75,906,675...77,649,964
Ensembl chr 3:75,906,695...77,649,964
|
|
G |
RUNX3 |
RUNX family transcription factor 3 |
|
IEP |
protein:decreased expression:bile duct |
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chr 1:24,899,511...24,965,138
Ensembl chr 1:24,899,511...24,965,121
|
|
G |
SLC4A4 |
solute carrier family 4 member 4 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087
|
|
G |
SLC5A5 |
solute carrier family 5 member 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408651 |
|
NCBI chr19:17,871,945...17,895,174
Ensembl chr19:17,871,945...17,895,174
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
disease_progression treatment |
IEP IMP |
|
RGD |
PMID:25475870 PMID:28347255 PMID:24131658 |
RGD:151361214, RGD:151361294, RGD:151361287 |
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507
|
|
G |
SMAD4 |
SMAD family member 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
severity |
IEP |
protein:decreased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOX17 |
SRY-box transcription factor 17 |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892
|
|
G |
SOX2 |
SRY-box transcription factor 2 |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
disease_progression |
IEP ISO |
protein:increased expression:pancreas |
RGD |
PMID:16083599 PMID:12632524 |
RGD:2325020, RGD:1299231 |
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFBR2 |
transforming growth factor beta receptor 2 |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249
|
|
G |
THBS1 |
thrombospondin 1 |
disease_progression |
IEP IDA |
DNA:hypermethylation (human) |
RGD |
PMID:16465407 PMID:11927969 PMID:12213730 |
RGD:2325024, RGD:2325027, RGD:2325026 |
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
|
|
G |
TNC |
tenascin C |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
|
|
G |
TNFAIP3 |
TNF alpha induced protein 3 |
severity |
IEP |
protein:increased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
|
|
G |
TP53 |
tumor protein p53 |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TTR |
transthyretin |
|
IEP |
protein:decreased expression:blood serum (human) |
RGD |
PMID:18275060 |
RGD:151660506 |
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
|
IEP |
|
RGD |
PMID:9230212 |
RGD:2325161 |
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
IAGP |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
WDHD1 |
WD repeat and HMG-box DNA binding protein 1 |
ameliorates |
IMP |
|
RGD |
PMID:30314946 |
RGD:156420141 |
NCBI chr14:54,938,949...55,027,099
Ensembl chr14:54,938,949...55,027,105
|
|
G |
WNT9A |
Wnt family member 9A |
disease_progression |
IEP |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 1:227,918,656...227,947,932
Ensembl chr 1:227,918,656...227,947,932
|
|
|
G |
CD40LG |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:23820408 |
RGD:11352285 |
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:22576464 |
RGD:10401932 |
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
severity |
IAGP |
associated with intrahepatic cholangiocarcinoma; DNA:missense mutations:cds:p. R132C, R132G, and R132L (human) |
RGD |
PMID:31121195 |
RGD:14974230 |
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
|
|
G |
MIR192 |
microRNA 192 |
|
IEP |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr11:64,891,137...64,891,246
Ensembl chr11:64,891,137...64,891,246
|
|
G |
MIR21 |
microRNA 21 |
|
IEP |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8698195 |
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
CA2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15816485 |
|
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:17102917 |
RGD:14995925 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:17102917 |
RGD:14995925 |
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
EGR1 |
early growth response 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
ITGB6 |
integrin subunit beta 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chr 2:160,099,671...160,200,272
Ensembl chr 2:160,099,667...160,271,888
|
|
G |
KRT19 |
keratin 19 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308
|
|
G |
MUC17 |
mucin 17, cell surface associated |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:19032457 |
RGD:2325170 |
NCBI chr 7:101,020,081...101,058,859
Ensembl chr 7:101,020,072...101,058,859
|
|
G |
MUC3A |
mucin 3A, cell surface associated |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:19032457 |
RGD:2325170 |
NCBI chr 7:100,949,534...100,968,347
Ensembl chr 7:100,949,534...100,968,347
|
|
G |
NRAS |
NRAS proto-oncogene, GTPase |
|
IEP |
mRNA:increased expression:cd4-positive helper T cells (human) |
RGD |
PMID:30690835 |
RGD:14975104 |
NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
|
|
G |
PKHD1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
|
RGD |
PMID:29158418 |
RGD:14700923 |
NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TLR2 |
toll like receptor 2 |
disease_progression |
ISO |
|
RGD |
PMID:30340822 |
RGD:15090860 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
VDR |
vitamin D receptor |
|
IEP |
mRNA,protein:decreased expression:liver |
RGD |
PMID:28146070 |
RGD:14401745 |
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
|
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
|
ISS |
OMIM:600803 |
MouseDO |
|
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
POT1 |
protection of telomeres 1 |
|
IEP |
mRNA:decreased expression:gall bladder |
RGD |
PMID:28643740 |
RGD:151356941 |
NCBI chr 7:124,822,386...124,929,825
Ensembl chr 7:124,822,386...124,929,983
|
|
|
G |
AQP1 |
aquaporin 1 (Colton blood group) |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
|
|
G |
CFTR |
CF transmembrane conductance regulator |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
PKHD1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
EXP ISO |
CTD Direct Evidence: marker/mechanism DNA:deletion:exon: |
CTD RGD |
PMID:18988797 PMID:15830394 |
RGD:14700991 |
NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613
|
|
G |
SCT |
secretin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chr11:626,309...627,181
Ensembl chr11:626,309...627,181
|
|
G |
SLC4A2 |
solute carrier family 4 member 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chr 7:151,058,200...151,076,527
Ensembl chr 7:151,057,210...151,076,526
|
|
|
G |
ASPG |
asparaginase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12902918 |
|
NCBI chr14:104,085,700...104,115,582
Ensembl chr14:104,085,686...104,115,582
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
treatment susceptibility |
ISO EXP |
mRNA:altered expression:liver (rat) protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11179459 PMID:22461449 PMID:24713091 PMID:12702498 PMID:27090119 PMID:27593105 PMID:29087027 More...
|
RGD:1598571, RGD:15090804, RGD:14402414, RGD:14402412 |
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
|
ISO IAGP ISS |
DNA:mutations: : |
MouseDO RGD |
PMID:11680581 PMID:26324191 |
RGD:1598589, RGD:11565494 |
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
treatment disease_progression |
ISO EXP IEP |
mRNA:altered expression:liver (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression:intestine: mRNA,protein:decreased expression:intestine: |
CTD RGD |
PMID:10869290 PMID:17681005 PMID:22521610 PMID:16037978 PMID:27090119 PMID:17009103 PMID:15057744 PMID:15057744 PMID:12702498 More...
|
RGD:1598614, RGD:15090804, RGD:11081011, RGD:11081007, RGD:11081007, RGD:1598571 |
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
|
ISO EXP |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22461449 PMID:18096675 PMID:23486593 |
RGD:2301060, RGD:11535162 |
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
treatment |
ISO |
protein:altered expression:kidney, liver |
RGD |
PMID:15030973 PMID:30223280 |
RGD:2301085, RGD:15045612 |
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABCG5 |
ATP binding cassette subfamily G member 5 |
|
ISO |
|
RGD |
PMID:16764892 |
RGD:1598662 |
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
|
|
G |
ABCG8 |
ATP binding cassette subfamily G member 8 |
|
ISO |
|
RGD |
PMID:16764892 |
RGD:1598662 |
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:30458228 |
RGD:25671450 |
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ADAMTS13 |
ADAM metallopeptidase with thrombospondin type 1 motif 13 |
|
ISO |
mRNA, protein:increased expression, increased activity:liver, plasma (rat) |
RGD |
PMID:19652891 |
RGD:2315953 |
NCBI chr 9:133,414,337...133,459,386
Ensembl chr 9:133,414,358...133,459,402
|
|
G |
ADH5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:19806079 |
RGD:5129088 |
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
|
|
G |
AGT |
angiotensinogen |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
ALB |
albumin |
|
IEP |
|
RGD |
PMID:6431134 |
RGD:11035297 |
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALDH1B1 |
aldehyde dehydrogenase 1 family member B1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 9:38,392,702...38,398,661
Ensembl chr 9:38,392,702...38,398,661
|
|
G |
ALDH1L1 |
aldehyde dehydrogenase 1 family member L1 |
treatment |
ISO |
|
RGD |
PMID:30223280 |
RGD:15045612 |
NCBI chr 3:126,103,570...126,197,945
Ensembl chr 3:126,103,562...126,197,994
|
|
G |
ALDH8A1 |
aldehyde dehydrogenase 8 family member A1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 6:134,917,393...134,950,101
Ensembl chr 6:134,917,393...134,950,115
|
|
G |
APOC3 |
apolipoprotein C3 |
|
ISO |
|
RGD |
PMID:17201892 |
RGD:10054045 |
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
|
|
G |
APOE |
apolipoprotein E |
|
IEP |
associated with Pancreatic Neoplasms;protein:increased expression:plasma |
RGD |
PMID:19055369 |
RGD:2317548 |
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
|
|
G |
ARG1 |
arginase 1 |
|
ISO |
protein:altered activity:liver (rat) |
RGD |
PMID:15916970 |
RGD:4143230 |
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
|
|
G |
BCAT1 |
branched chain amino acid transaminase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr12:24,810,024...24,949,340
Ensembl chr12:24,810,024...24,949,101
|
|
G |
BEX4 |
brain expressed X-linked 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr X:103,215,092...103,217,246
Ensembl chr X:103,215,108...103,217,246
|
|
G |
BLVRA |
biliverdin reductase A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18706437 |
|
NCBI chr 7:43,758,122...43,807,342
Ensembl chr 7:43,758,680...43,807,342
|
|
G |
BMAL1 |
basic helix-loop-helix ARNT like 1 |
|
ISO |
mRNA:increased expression:cholangiocyte |
RGD |
PMID:21757639 |
RGD:10043349 |
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
|
|
G |
BTG3 |
BTG anti-proliferation factor 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945
|
|
G |
C4orf19 |
chromosome 4 open reading frame 19 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 4:37,453,255...37,593,510
Ensembl chr 4:37,453,925...37,623,495
|
|
G |
CADPS2 |
calcium dependent secretion activator 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759
|
|
G |
CAT |
catalase |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27989131 PMID:21339256 |
RGD:5130873 |
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:22511970 |
RGD:7183752 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD44 |
CD44 molecule (IN blood group) |
|
ISO |
protein:decreased expression:jejunum, ileum |
RGD |
PMID:16804311 |
RGD:2289372 |
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
CFHR5 |
complement factor H related 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:196,975,034...197,009,678
Ensembl chr 1:196,975,010...197,009,678
|
|
G |
CFTR |
CF transmembrane conductance regulator |
|
ISO |
mRNA,Protein:increased expression |
RGD |
PMID:15605366 |
RGD:1599598 |
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CLOCK |
clock circadian regulator |
|
ISO |
mRNA:increased expression:cholangiocyte |
RGD |
PMID:21757639 |
RGD:10043349 |
NCBI chr 4:55,427,903...55,546,909
Ensembl chr 4:55,427,903...55,546,909
|
|
G |
CNR1 |
cannabinoid receptor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26884397 |
|
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
|
|
G |
CNR2 |
cannabinoid receptor 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26884397 |
|
NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
treatment |
ISO |
mRNA:increased expression:liver (mouse) mRNA:increased expression:liver (rat) |
RGD |
PMID:22094456 PMID:22824087 PMID:21274875 |
RGD:8552675, RGD:8552776, RGD:8552699 |
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
CP |
ceruloplasmin |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:29523470 |
RGD:14401716 |
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
IEP |
associated with Chronic Hepatitis C; protein:increased expression:serum: |
RGD |
PMID:30507970 |
RGD:27095896 |
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27565560 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP27A1 |
cytochrome P450 family 27 subfamily A member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15795599 |
|
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461449 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
disease_progression |
ISO |
|
RGD |
PMID:29204052 |
RGD:13782189 |
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
treatment |
EXP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9797378 PMID:22461449 PMID:29655695 |
RGD:15090803 |
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
CYP7B1 |
cytochrome P450 family 7 subfamily B member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9802883 |
|
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
|
|
G |
CYP8B1 |
cytochrome P450 family 8 subfamily B member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461449 |
|
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
|
|
G |
DGAT2 |
diacylglycerol O-acyltransferase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
|
|
G |
DNAJB9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
|
|
G |
DNAJC12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr10:67,796,669...67,838,188
Ensembl chr10:67,796,669...67,838,188
|
|
G |
EGR1 |
early growth response 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EHHADH |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
|
IAGP |
ClinVar Annotator: match by term: Cholestasis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990
|
|
G |
ENG |
endoglin |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,811,130...127,854,773
|
|
G |
ERLEC1 |
endoplasmic reticulum lectin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 2:53,787,044...53,818,796
Ensembl chr 2:53,787,009...53,833,038
|
|
G |
F2RL3 |
F2R like thrombin or trypsin receptor 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr19:16,888,999...16,892,606
Ensembl chr19:16,888,999...16,892,606
|
|
G |
FGA |
fibrinogen alpha chain |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
ISO |
|
RGD |
PMID:18802767 |
RGD:2307352 |
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GHR |
growth hormone receptor |
|
ISO |
mRNA,protein:decreased expression:liver, skeletal muscle: |
RGD |
PMID:15604202 |
RGD:11567216 |
NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
treatment |
ISO |
|
RGD |
PMID:25932098 |
RGD:14701043 |
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
|
RGD |
PMID:23960717 |
RGD:10401941 |
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GTPBP2 |
GTP binding protein 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 6:43,620,494...43,631,333
Ensembl chr 6:43,605,316...43,629,264
|
|
G |
HACL1 |
2-hydroxyacyl-CoA lyase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 3:15,560,699...15,601,569
Ensembl chr 3:15,560,699...15,601,852
|
|
G |
HAO2 |
hydroxyacid oxidase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130
|
|
G |
HJV |
hemojuvelin BMP co-receptor |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746
|
|
G |
HOGA1 |
4-hydroxy-2-oxoglutarate aldolase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr10:97,584,389...97,612,802
Ensembl chr10:97,584,323...97,612,802
|
|
G |
HP |
haptoglobin |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:12940443 |
RGD:1626374 |
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
|
|
G |
HSD3B7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25526675 |
|
NCBI chr16:30,985,207...30,989,147
Ensembl chr16:30,985,207...30,989,147
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
|
ISO |
protein:increased expression:liver, nucleus (rat) |
RGD |
PMID:16628634 |
RGD:9686088 |
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,573,014...31,606,515
|
|
G |
ID4 |
inhibitor of DNA binding 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197
|
|
G |
IGF1 |
insulin like growth factor 1 |
|
ISO EXP |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:12826230 PMID:18607346 |
RGD:10046052 |
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:19535096 |
RGD:2311076 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL2 |
interleukin 2 |
treatment |
ISO |
|
RGD |
PMID:29698570 |
RGD:14928214 |
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
|
RGD |
PMID:20031157 |
RGD:2317270 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6 |
interleukin 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461449 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INVS |
inversin |
|
ISO |
|
RGD |
PMID:10421642 |
RGD:155791685 |
NCBI chr 9:100,099,243...100,302,175
Ensembl chr 9:100,099,243...100,302,175
|
|
G |
KANK1 |
KN motif and ankyrin repeat domains 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 9:470,295...746,103
Ensembl chr 9:470,291...746,105
|
|
G |
KMT2B |
lysine methyltransferase 2B |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:21330447 |
RGD:9588602 |
NCBI chr19:35,718,003...35,738,878
Ensembl chr19:35,717,973...35,738,880
|
|
G |
LAMP2 |
lysosomal associated membrane protein 2 |
|
ISO |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
|
|
G |
LY96 |
lymphocyte antigen 96 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079
|
|
G |
MAOB |
monoamine oxidase B |
|
ISO |
protein:altered activity:hypothalamus (rat) |
RGD |
PMID:18802767 |
RGD:2307352 |
NCBI chr X:43,766,610...43,882,450
Ensembl chr X:43,766,610...43,882,450
|
|
G |
MAPK13 |
mitogen-activated protein kinase 13 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chr 6:36,130,513...36,144,521
Ensembl chr 6:36,127,809...36,144,524
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,752...36,122,511
|
|
G |
MBOAT1 |
membrane bound O-acyltransferase domain containing 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 6:20,099,684...20,212,469
Ensembl chr 6:20,099,684...20,212,469
|
|
G |
MIR130B |
microRNA 130b |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr22:21,653,304...21,653,385
Ensembl chr22:21,653,304...21,653,385
|
|
G |
MIR143 |
microRNA 143 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30125006 |
|
NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
|
|
G |
MIR185 |
microRNA 185 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr22:20,033,139...20,033,220
Ensembl chr22:20,033,139...20,033,220
|
|
G |
MIR190A |
microRNA 190a |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr15:62,823,957...62,824,041
Ensembl chr15:62,823,957...62,824,041
|
|
G |
MIR218-1 |
microRNA 218-1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 PMID:30125006 |
|
NCBI chr 4:20,528,275...20,528,384
Ensembl chr 4:20,528,275...20,528,384
|
|
G |
MIR24-1 |
microRNA 24-1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 9:95,086,021...95,086,088
Ensembl chr 9:95,086,021...95,086,088
|
|
G |
MIR27B |
microRNA 27b |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 9:95,085,445...95,085,541
Ensembl chr 9:95,085,445...95,085,541
|
|
G |
MIR337 |
microRNA 337 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr14:100,874,493...100,874,585
Ensembl chr14:100,874,493...100,874,585
|
|
G |
MIR361 |
microRNA 361 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr X:85,903,636...85,903,707
Ensembl chr X:85,903,636...85,903,707
|
|
G |
MIR377 |
microRNA 377 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr14:101,062,050...101,062,118
Ensembl chr14:101,062,050...101,062,118
|
|
G |
MIR411 |
microRNA 411 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr14:101,023,325...101,023,420
Ensembl chr14:101,023,325...101,023,420
|
|
G |
MIR875 |
microRNA 875 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 8:99,536,786...99,536,861
Ensembl chr 8:99,536,786...99,536,861
|
|
G |
MIR99A |
microRNA 99a |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr21:16,539,089...16,539,169
Ensembl chr21:16,539,089...16,539,169
|
|
G |
MIRLET7B |
microRNA let-7b |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr22:46,113,686...46,113,768
Ensembl chr22:46,113,686...46,113,768
|
|
G |
MIRLET7I |
microRNA let-7i |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
treatment |
ISO |
|
RGD |
PMID:21274875 |
RGD:8552699 |
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20977460 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFXL1 |
nuclear transcription factor, X-box binding like 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 4:47,847,233...47,914,667
Ensembl chr 4:47,847,233...47,914,667
|
|
G |
NIBAN1 |
niban apoptosis regulator 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:184,791,032...184,974,508
Ensembl chr 1:184,790,724...184,974,508
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12612912 PMID:20626112 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:11352814 |
RGD:7775033 |
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NPHP4 |
nephrocystin 4 |
|
IAGP |
ClinVar Annotator: match by term: Cholestasis |
ClinVar |
PMID:15776426 PMID:22550138 PMID:25741868 PMID:28492532 PMID:28700940 |
|
NCBI chr 1:5,862,811...5,992,425
Ensembl chr 1:5,862,811...5,992,473
|
|
G |
NPL |
N-acetylneuraminate pyruvate lyase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:182,789,773...182,830,384
Ensembl chr 1:182,789,293...182,830,384
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22461449 PMID:28337145 |
RGD:13439750 |
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR1D1 |
nuclear receptor subfamily 1 group D member 1 |
|
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
|
|
G |
NR1H2 |
nuclear receptor subfamily 1 group H member 2 |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chr19:50,376,457...50,383,388
Ensembl chr19:50,329,653...50,383,388
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
treatment severity |
EXP ISO |
CTD Direct Evidence: marker/mechanism mRNA:altered expression:liver (rat) mRNA:increased expression:ileum (rat) mRNA, protein:altered expression:liver (rat) mutant FXR-/- mouse |
CTD RGD |
PMID:22461449 PMID:23178280 PMID:27090119 PMID:30061734 PMID:30223280 PMID:30077711 PMID:29235094 PMID:12949728 More...
|
RGD:15090804, RGD:15092071, RGD:15045612, RGD:15045597, RGD:15042872, RGD:14701031 |
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
disease_progression |
ISO |
|
RGD |
PMID:29204052 |
RGD:13782189 |
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
disease_progression |
ISO |
|
RGD |
PMID:29204052 |
RGD:13782189 |
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
|
|
G |
OTC |
ornithine transcarbamylase |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:15916970 |
RGD:4143230 |
NCBI chr X:38,327,684...38,422,928
Ensembl chr X:38,327,598...38,422,908
|
|
G |
PAN2 |
poly(A) specific ribonuclease subunit PAN2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr12:56,316,936...56,334,000
Ensembl chr12:56,316,223...56,334,053
|
|
G |
PDGFB |
platelet derived growth factor subunit B |
|
ISO |
mRNA,protein:increased expression:cholangiocyte, bible duct: |
RGD |
PMID:10424289 |
RGD:10449495 |
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
|
|
G |
PDYN |
prodynorphin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16919318 |
|
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
|
|
G |
POMC |
proopiomelanocortin |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:3421781 |
|
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
|
|
G |
PON1 |
paraoxonase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
treatment |
ISO |
mRNA:altered expression:liver (rat) |
RGD |
PMID:27090119 |
RGD:15090804 |
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PYGM |
glycogen phosphorylase, muscle associated |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:11804660 |
RGD:1599990 |
NCBI chr11:64,746,389...64,760,715
Ensembl chr11:64,746,389...64,759,974
|
|
G |
RDX |
radixin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17681005 |
|
NCBI chr11:110,174,922...110,296,614
Ensembl chr11:109,864,295...110,296,712
|
|
G |
REEP5 |
receptor accessory protein 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 5:112,876,385...112,922,227
Ensembl chr 5:112,876,385...112,922,289
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RFLNB |
refilin B |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr17:439,978...445,940
Ensembl chr17:439,978...445,939
|
|
G |
SERPINA1 |
serpin family A member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:4117022 |
|
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
|
|
G |
SERPINA5 |
serpin family A member 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr14:94,581,426...94,593,118
Ensembl chr14:94,561,442...94,593,118
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC10A1 |
solute carrier family 10 member 1 |
treatment |
ISO |
mRNA:altered expression:liver (rat) |
RGD |
PMID:29655695 PMID:27090119 |
RGD:15090803, RGD:15090804 |
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
|
|
G |
SLC10A7 |
solute carrier family 10 member 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 4:146,253,981...146,521,940
Ensembl chr 4:146,253,975...146,522,372
|
|
G |
SLC16A2 |
solute carrier family 16 member 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr X:74,421,493...74,533,916
Ensembl chr X:74,421,493...74,533,917
|
|
G |
SLC23A1 |
solute carrier family 23 member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18706437 |
|
NCBI chr 5:139,367,196...139,385,676
Ensembl chr 5:139,367,196...139,384,553
|
|
G |
SLC23A2 |
solute carrier family 23 member 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18706437 |
|
NCBI chr20:4,852,358...5,010,313
Ensembl chr20:4,852,356...5,010,293
|
|
G |
SLC30A10 |
solute carrier family 30 member 10 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 1:219,910,445...219,959,098
Ensembl chr 1:219,685,427...219,959,018
|
|
G |
SLC51A |
solute carrier family 51 member A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16423920 PMID:22461449 |
|
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
|
|
G |
SLC51B |
SLC51 subunit beta |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16423920 PMID:22461449 |
|
NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
treatment |
ISO |
mRNA:altered expression:liver (rat) |
RGD |
PMID:27090119 |
RGD:15090804 |
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
|
|
G |
SLCO1B3 |
solute carrier organic anion transporter family member 1B3 |
|
ISO |
mRNA, protein:increased expression:hepatocyte |
RGD |
PMID:17916651 |
RGD:2303109 |
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
|
|
G |
SNAI1 |
snail family transcriptional repressor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
|
|
G |
SORL1 |
sortilin related receptor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
|
|
G |
SORT1 |
sortilin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28453831 |
|
NCBI chr 1:109,309,575...109,397,918
Ensembl chr 1:109,309,568...109,397,918
|
|
G |
SPINT1 |
serine peptidase inhibitor, Kunitz type 1 |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chr15:40,844,048...40,858,207
Ensembl chr15:40,844,018...40,858,207
|
|
G |
SPINT2 |
serine peptidase inhibitor, Kunitz type 2 |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chr19:38,264,573...38,292,615
Ensembl chr19:38,244,035...38,292,615
|
|
G |
SRP72 |
signal recognition particle 72 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681
|
|
G |
SULT2B1 |
sulfotransferase family 2B member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27052460 |
|
NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
|
RGD |
PMID:8707259 |
RGD:2290364 |
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TJP1 |
tight junction protein 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:18197414 |
RGD:2325141 |
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
G |
TLR2 |
toll like receptor 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TMED7 |
transmembrane p24 trafficking protein 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 5:115,613,210...115,626,036
Ensembl chr 5:115,613,210...115,632,992
|
|
G |
TMEM117 |
transmembrane protein 117 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr12:43,795,802...44,399,108
Ensembl chr12:43,835,967...44,389,762
|
|
G |
TNF |
tumor necrosis factor |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TRAJ18 |
T cell receptor alpha joining 18 |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:32987112 |
|
NCBI chr14:22,525,650...22,525,715
Ensembl chr14:22,525,650...22,525,715
|
|
G |
UBA5 |
ubiquitin like modifier activating enzyme 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 3:132,654,430...132,679,794
Ensembl chr 3:132,654,446...132,679,794
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
treatment |
ISO |
|
RGD |
PMID:29867509 |
RGD:14694823 |
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
USP53 |
ubiquitin specific peptidase 53 |
|
IAGP |
ClinVar Annotator: match by term: Cholestasis |
ClinVar |
PMID:25741868 PMID:28492532 PMID:32124521 PMID:32759993 PMID:34608165 |
|
NCBI chr 4:119,212,601...119,295,518
Ensembl chr 4:119,212,587...119,295,518
|
|
G |
UTP4 |
UTP4 small subunit processome component |
|
IAGP |
North American Indian childhood cirrhosis, OMIM:604901, R565W |
RGD |
PMID:12417987 |
RGD:1600653 |
NCBI chr16:69,132,649...69,169,021
Ensembl chr16:69,131,291...69,231,130
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VIL1 |
villin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr 2:218,419,123...218,453,295
Ensembl chr 2:218,419,121...218,453,295
|
|
G |
VPS33B |
VPS33B late endosome and lysosome associated |
|
IAGP |
ARC syndrome, OMIM:208085 |
RGD |
PMID:15052268 |
RGD:1599749 |
NCBI chr15:90,998,416...91,022,621
Ensembl chr15:90,998,673...91,022,603
|
|
G |
WIPI1 |
WD repeat domain, phosphoinositide interacting 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
|
|
G |
XDH |
xanthine dehydrogenase |
|
ISO |
protein:alternative form:liver |
RGD |
PMID:10898233 |
RGD:13209135 |
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
|
ISO |
|
RGD |
PMID:17852852 |
RGD:14694983 |
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
|
G |
AHI1 |
Abelson helper integration site 1 |
|
IAGP |
ClinVar Annotator: match by term: Joubert syndrome with ocular defect |
ClinVar |
PMID:15322546 PMID:16453322 PMID:18054307 PMID:21623382 PMID:21937992 PMID:25525159 PMID:25741868 PMID:26092869 PMID:28442542 PMID:28492532 PMID:29186038 More...
|
|
NCBI chr 6:135,283,532...135,497,740
Ensembl chr 6:135,283,407...135,498,434
|
|
G |
OFD1 |
OFD1 centriole and centriolar satellite protein |
|
IAGP |
ClinVar Annotator: match by term: Joubert syndrome with congenital hepatic fibrosis |
ClinVar |
PMID:16783569 PMID:18546297 PMID:27081566 PMID:28492532 |
|
NCBI chr X:13,714,505...13,773,738
Ensembl chr X:13,734,743...13,777,955
|
|
G |
TMEM67 |
transmembrane protein 67 |
|
IAGP EXP |
DNA:missense mutations: :multiple CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19058225 PMID:19574260 |
RGD:11535944, RGD:11535946 |
NCBI chr 8:93,754,844...93,832,653
Ensembl chr 8:93,754,844...93,819,234
|
|
|
G |
CC2D2A |
coiled-coil and C2 domain containing 2A |
|
IAGP |
ClinVar Annotator: match by term: COACH syndrome 1 |
ClinVar |
PMID:18414213 PMID:18950740 PMID:19777577 PMID:21068128 PMID:22241855 PMID:22425360 PMID:23012439 PMID:24706459 PMID:25741868 PMID:26092869 PMID:26477546 PMID:26485645 PMID:26673778 PMID:26729329 PMID:27081510 PMID:27082236 PMID:28492532 PMID:28518168 PMID:29146704 PMID:29620724 PMID:32461654 More...
|
|
NCBI chr 4:15,469,865...15,601,557
Ensembl chr 4:15,469,865...15,601,552
|
|
G |
RPGRIP1L |
RPGRIP1 like |
|
IAGP |
ClinVar Annotator: match by term: COACH syndrome 1 |
ClinVar |
PMID:17558407 PMID:17558409 PMID:19430481 PMID:21866095 PMID:25741868 PMID:26092869 PMID:28492532 PMID:28771248 PMID:31390572 More...
|
|
NCBI chr16:53,598,153...53,703,859
Ensembl chr16:53,598,153...53,703,938
|
|
G |
TMEM67 |
transmembrane protein 67 |
|
IAGP |
ClinVar Annotator: match by term: COACH syndrome 1 |
OMIM ClinVar |
PMID:2929661 PMID:8862632 PMID:9375913 PMID:9536098 PMID:12368986 PMID:17160906 PMID:17377820 PMID:17397051 PMID:17576681 PMID:18327255 PMID:18414213 PMID:19058225 PMID:19466712 PMID:19508969 PMID:19540516 PMID:19574260 PMID:20232449 PMID:20607301 PMID:21068128 PMID:21633164 PMID:21866095 PMID:22700954 PMID:23351400 PMID:23559409 PMID:24033266 PMID:25326635 PMID:25412400 PMID:25741868 PMID:25920555 PMID:26035863 PMID:26092869 PMID:26467025 PMID:26729329 PMID:27434533 PMID:27491411 PMID:28125082 PMID:28492532 PMID:28497568 PMID:28680603 PMID:28719906 PMID:28771248 PMID:28973083 PMID:29127258 PMID:29146704 PMID:29568536 PMID:29891882 PMID:29974258 PMID:30029678 PMID:30476936 PMID:34675960 PMID:36617405 More...
|
|
NCBI chr 8:93,754,844...93,832,653
Ensembl chr 8:93,754,844...93,819,234
|
|
|
G |
CC2D2A |
coiled-coil and C2 domain containing 2A |
|
IAGP |
ClinVar Annotator: match by term: COACH syndrome 2 |
OMIM ClinVar |
PMID:18950740 PMID:19466712 PMID:19574260 PMID:19777577 PMID:22241855 PMID:22246503 PMID:25741868 PMID:26092869 PMID:28125082 PMID:28492532 PMID:32488064 More...
|
|
NCBI chr 4:15,469,865...15,601,557
Ensembl chr 4:15,469,865...15,601,552
|
|
|
G |
RPGRIP1L |
RPGRIP1 like |
|
IAGP |
ClinVar Annotator: match by term: COACH syndrome 3 |
OMIM ClinVar |
PMID:9536098 PMID:17558407 PMID:17558409 PMID:17576681 PMID:17960139 PMID:18565097 PMID:19430481 PMID:19574260 PMID:21866095 PMID:25741868 PMID:26092869 PMID:27434533 PMID:28492532 PMID:28771248 PMID:31390572 More...
|
|
NCBI chr16:53,598,153...53,703,859
Ensembl chr16:53,598,153...53,703,938
|
|
|
G |
APOB |
apolipoprotein B |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:18076041 |
RGD:2325763 |
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
|
|
G |
FSCN1 |
fascin actin-bundling protein 1 |
|
IEP |
mRNA, protein:increased expression: : |
RGD |
PMID:15136764 |
RGD:2317789 |
NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655
|
|
G |
MSLN |
mesothelin |
|
IEP |
protein:increased expression:common bile duct, ampulla of vater |
RGD |
PMID:16416732 |
RGD:2326064 |
NCBI chr16:760,734...768,865
Ensembl chr16:760,734...768,865
|
|
G |
MTAP |
methylthioadenosine phosphorylase |
|
IEP |
DNA, protein:deletion, decreased expression:common bile duct: |
RGD |
PMID:15662124 |
RGD:2317954 |
NCBI chr 9:21,802,636...21,941,115
Ensembl chr 9:21,802,636...21,937,651
|
|
G |
MUC1 |
mucin 1, cell surface associated |
disease_progression |
IEP |
protein:increased expression:bile duct |
RGD |
PMID:8766528 |
RGD:2324856 |
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
|
|
G |
MUC4 |
mucin 4, cell surface associated |
|
IEP |
protein:increased expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chr 3:195,746,771...195,811,929
Ensembl chr 3:195,746,765...195,811,973
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
IEP |
protein:altered expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
TYMP |
thymidine phosphorylase |
disease_progression |
IEP |
|
RGD |
PMID:10760693 |
RGD:2325158 |
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
|
|
|
G |
AKR1D1 |
aldo-keto reductase family 1 member D1 |
|
IAGP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect |
ClinVar |
|
|
NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305
|
|
G |
CYP7B1 |
cytochrome P450 family 7 subfamily B member 1 |
|
IAGP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
|
|
|
G |
HSD3B7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
IAGP EXP |
ClinVar Annotator: match by term: HSD3B7-related condition ClinVar Annotator: match by term: Congenital bile acid synthesis defect 1 | ClinVar Annotator: match by term: HSD3B7-related condition ClinVar Annotator: match by term: 3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE DEFICIENCY | ClinVar Annotator: match by term: Congenital bile acid synthesis defect 1 | ClinVar Annotator: match by term: HSD3B7-related condition CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:3470305 PMID:11067870 PMID:12679481 PMID:25741868 PMID:26712441 PMID:28492532 PMID:34627351 More...
|
|
NCBI chr16:30,985,207...30,989,147
Ensembl chr16:30,985,207...30,989,147
|
|
|
G |
AKR1D1 |
aldo-keto reductase family 1 member D1 |
|
IAGP EXP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 2 CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:8707100 PMID:12970144 PMID:15030995 PMID:16199547 PMID:18243262 PMID:19175828 PMID:20522910 PMID:21185810 PMID:23679950 PMID:25304492 PMID:25741868 PMID:28492532 PMID:30809085 PMID:31450232 PMID:37314652 PMID:38062451 More...
|
|
NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305
|
|
|
G |
CYP7B1 |
cytochrome P450 family 7 subfamily B member 1 |
|
IAGP EXP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 3 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:1943942 PMID:9802883 PMID:18252231 PMID:18367963 PMID:19363635 PMID:19439420 PMID:19812052 PMID:21541746 PMID:21567895 PMID:21623769 PMID:22384504 PMID:23812641 PMID:24117163 PMID:24641183 PMID:24927729 PMID:25741868 PMID:26467025 PMID:27077743 PMID:27217339 PMID:27879216 PMID:27957547 PMID:28039895 PMID:28492532 PMID:28832565 PMID:29228183 PMID:29980238 More...
|
|
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
|
|
G |
LOC130000507 |
ATAC-STARR-seq lymphoblastoid silent region 19243 |
|
IAGP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 3 |
ClinVar |
PMID:25741868 |
|
NCBI chr 8:64,798,535...64,798,644
|
|
|
G |
AMACR |
alpha-methylacyl-CoA racemase |
|
IAGP EXP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 4 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:9584266 PMID:10655068 PMID:12512044 PMID:15249642 PMID:18032455 PMID:20818383 PMID:20821052 PMID:21576695 PMID:21686617 PMID:25741868 PMID:28492532 PMID:30369941 More...
|
|
NCBI chr 5:33,986,165...34,008,050
Ensembl chr 5:33,986,165...34,008,104
|
|
G |
C1QTNF3-AMACR |
C1QTNF3-AMACR readthrough (NMD candidate) |
|
IAGP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 4 |
ClinVar |
PMID:9584266 PMID:10655068 PMID:12512044 PMID:15249642 PMID:18032455 PMID:20818383 PMID:20821052 PMID:21576695 PMID:21686617 PMID:25741868 PMID:28492532 PMID:30369941 More...
|
|
NCBI chr 5:33,986,986...34,124,528
Ensembl chr 5:33,987,174...34,124,528
|
|
G |
SLC45A2 |
solute carrier family 45 member 2 |
|
IAGP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 4 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 5:33,944,623...33,984,693
Ensembl chr 5:33,944,623...33,984,693
|
|
|
G |
ABCD3 |
ATP binding cassette subfamily D member 3 |
|
IAGP ISS |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 5 ClinVar Annotator: match by term: ABCD3-related condition | ClinVar Annotator: match by term: Congenital bile acid synthesis defect 5 OMIM:616278 |
ClinVar MouseDO OMIM |
PMID:25168382 PMID:25741868 PMID:28492532 |
|
NCBI chr 1:94,385,131...94,518,663
Ensembl chr 1:94,418,389...94,518,666
|
|
|
G |
ACOX2 |
acyl-CoA oxidase 2 |
|
IAGP |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 6 ClinVar Annotator: match by term: ACOX2-related condition ClinVar Annotator: match by term: ACOX2-related condition | ClinVar Annotator: match by term: Congenital bile acid synthesis defect 6 |
ClinVar OMIM |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:25741868 PMID:27647924 PMID:27884763 PMID:28492532 PMID:35395098 PMID:35775617 More...
|
|
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
|
|
|
G |
BAP1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
IAGP |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
|
|
G |
PBRM1 |
polybromo 1 |
disease_progression |
IAGP |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chr 3:52,545,367...52,685,913
Ensembl chr 3:52,545,352...52,685,917
|
|
G |
RAC1 |
Rac family small GTPase 1 |
|
IEP |
protein:increased expression:mucosa (human) |
RGD |
PMID:21537609 |
RGD:153350126 |
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
disease_progression |
IEP |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507
|
|
|
G |
PKD1 |
polycystin 1, transient receptor potential channel interacting |
|
IAGP |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 |
|
NCBI chr16:2,088,708...2,135,898
Ensembl chr16:2,088,708...2,135,898
|
|
G |
POLD1 |
DNA polymerase delta 1, catalytic subunit |
|
IAGP |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chr19:50,384,323...50,418,018
Ensembl chr19:50,384,204...50,418,018
|
|
G |
XPO1 |
exportin 1 |
disease_progression |
IEP |
protein:increased expression:extrahepatic bile duct (human) |
RGD |
PMID:27279267 |
RGD:151665800 |
NCBI chr 2:61,477,849...61,538,612
Ensembl chr 2:61,476,032...61,538,741
|
|
|
G |
ABCA1 |
ATP binding cassette subfamily A member 1 |
|
ISO |
mRNA,protein:increased expression:liver, basolateral plasma membrane (rat) |
RGD |
PMID:28660384 |
RGD:21203516 |
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
treatment |
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29360226 |
RGD:14995480 |
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:31932644 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
G |
ALB |
albumin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
CCN2 |
cellular communication network factor 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CD68 |
CD68 molecule |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:31932644 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
CRH |
corticotropin releasing hormone |
|
ISO |
protein:decreased expression:hypothalamus (rat) |
RGD |
PMID:8387536 |
RGD:5490980 |
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
|
|
G |
CYGB |
cytoglobin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175
|
|
G |
CYP27A1 |
cytochrome P450 family 27 subfamily A member 1 |
treatment |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:29360226 |
RGD:14995480 |
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
treatment |
ISO |
mRNA:decreased expression:liver (rat) mRNA:decreased expression:liver, nucleus (rat) |
RGD |
PMID:29360226 PMID:28660384 |
RGD:14995480, RGD:21203516 |
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
CYP8B1 |
cytochrome P450 family 8 subfamily B member 1 |
treatment |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:29360226 |
RGD:14995480 |
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
GJB1 |
gap junction protein beta 1 |
|
ISO |
mRNA,protein:decreased expression:liver: |
RGD |
PMID:7762611 |
RGD:7349397 |
NCBI chr X:71,215,239...71,225,516
Ensembl chr X:71,212,811...71,225,516
|
|
G |
GJB2 |
gap junction protein beta 2 |
|
ISO |
|
RGD |
PMID:7762611 |
RGD:7349397 |
NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:19652645 |
RGD:11041639 |
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
|
|
G |
HMGB1 |
high mobility group box 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMGCS2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
|
ISO |
mRNA, protein:decreased expression:liver, mitochondrion (rat) |
RGD |
PMID:12399220 |
RGD:2326121 |
NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
|
|
G |
HNF1A |
HNF1 homeobox A |
|
ISO |
mRNA,protein,DNA:decreased expression, decreased binding, decreased expression:liver, nuclear (rat) |
RGD |
PMID:15723437 |
RGD:14700989 |
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
|
|
G |
IL1B |
interleukin 1 beta |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
LGALS1 |
galectin 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:18225978 |
RGD:2316551 |
NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
|
|
G |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,752...36,122,511
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
treatment |
EXP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:30026087 PMID:31900718 |
RGD:21201303 |
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
treatment disease_progression |
ISO IMP |
mRNA:increased expression:liver (rat) protein:increased expression:liver (rat) human gene in mouse model |
RGD |
PMID:14623915 PMID:29360226 PMID:29138817 PMID:22057115 |
RGD:1625205, RGD:14995480, RGD:15042871, RGD:14928333 |
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
OPRM1 |
opioid receptor mu 1 |
|
ISO |
mRNA:decreased expression:hypothalamus, hippocampus |
RGD |
PMID:25290008 |
RGD:401842371 |
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
|
|
G |
PDGFRB |
platelet derived growth factor receptor beta |
treatment |
ISO |
|
RGD |
PMID:18466260 |
RGD:10449503 |
NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872
|
|
G |
PTN |
pleiotrophin |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:18225978 |
RGD:2316551 |
NCBI chr 7:137,227,341...137,343,733
Ensembl chr 7:137,227,341...137,343,774
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:30026087 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SETD7 |
SET domain containing 7, histone lysine methyltransferase |
treatment |
ISO |
|
RGD |
PMID:24097032 |
RGD:9491846 |
NCBI chr 4:139,492,974...139,556,219
Ensembl chr 4:139,495,941...139,606,699
|
|
G |
SLC22A1 |
solute carrier family 22 member 1 |
|
ISO |
protein:decreased expression:kidney |
RGD |
PMID:20814153 |
RGD:7243879 |
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20814153 |
RGD:7243879 |
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:30026087 PMID:31932644 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
|
|
G |
TLR4 |
toll like receptor 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
TJP2 |
tight junction protein 2 |
|
IAGP |
ClinVar Annotator: match by term: Familial primary biliary cirrhosis |
ClinVar |
PMID:25741868 PMID:28492532 PMID:32439973 |
|
NCBI chr 9:69,121,264...69,255,208
Ensembl chr 9:69,121,264...69,274,615
|
|
|
G |
CTSB |
cathepsin B |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:19696938 |
RGD:2315504 |
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
|
|
G |
GLUD1 |
glutamate dehydrogenase 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:10431747 |
RGD:6484593 |
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
|
|
|
G |
BCS1L |
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone |
|
IAGP ISS EXP |
ClinVar Annotator: match by term: GRACILE syndrome OMIM:603358 CTD Direct Evidence: marker/mechanism |
ClinVar MouseDO CTD OMIM |
PMID:9545407 PMID:11528392 PMID:12215968 PMID:12547234 PMID:12910490 PMID:16199547 PMID:17314340 PMID:17403714 PMID:18386115 PMID:18771761 PMID:19162478 PMID:19285991 PMID:19389488 PMID:19508421 PMID:20518024 PMID:21274865 PMID:22277166 PMID:22310368 PMID:23892085 PMID:24033266 PMID:24172246 PMID:24236502 PMID:24655110 PMID:24704045 PMID:25741868 PMID:25895478 PMID:25914718 PMID:25954003 PMID:26467025 PMID:26489029 PMID:26563427 PMID:27618451 PMID:27959697 PMID:28105683 PMID:28128857 PMID:28322498 PMID:28427446 PMID:28490743 PMID:28492532 PMID:28496993 PMID:29090881 PMID:30582773 PMID:30634555 PMID:31435670 PMID:32313153 PMID:32552793 PMID:33511646 PMID:34645488 PMID:34662929 More...
|
|
NCBI chr 2:218,658,743...218,663,443
Ensembl chr 2:218,658,764...218,663,443
|
|
G |
LOC129935609 |
ATAC-STARR-seq lymphoblastoid active region 17127 |
|
IAGP |
ClinVar Annotator: match by term: GRACILE syndrome |
ClinVar |
PMID:25741868 |
|
NCBI chr 2:218,659,677...218,659,806
|
|
G |
MT-TS1 |
mitochondrially encoded tRNA-Ser (UCN) 1 |
|
IAGP |
ClinVar Annotator: match by term: neonatal lactic acidosis |
ClinVar |
PMID:25741868 PMID:32313153 |
|
NCBI chr MT:7,446...7,514
Ensembl chr MT:7,446...7,514
|
|
|
G |
LOC126863275 |
BRD4-independent group 4 enhancer GRCh37_chrX:70342400-70343599 |
|
IAGP |
ClinVar Annotator: match by term: Cholestasis-pigmentary retinopathy-cleft palate syndrome |
ClinVar |
|
|
NCBI chr X:71,122,550...71,123,749
|
|
G |
MED12 |
mediator complex subunit 12 |
|
IAGP |
ClinVar Annotator: match by term: Hardikar syndrome ClinVar Annotator: match by term: Cholestasis-pigmentary retinopathy-cleft palate syndrome | ClinVar Annotator: match by term: Hardikar syndrome |
OMIM ClinVar |
PMID:9286458 PMID:20301719 PMID:24728327 PMID:25741868 PMID:28492532 PMID:30006928 PMID:32174975 PMID:33244165 PMID:33244166 PMID:33913598 PMID:34079076 More...
|
|
NCBI chr X:71,118,596...71,142,450
Ensembl chr X:71,118,543...71,144,103
|
|
|
G |
ANK1 |
ankyrin 1 |
severity |
IAGP ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant DNA:deletion mutation:exon: DNA:deletion:cds: DNA:mutation: : DNA:transversion mutation:splice site:1674G>C(mouse) DNA:transition mutation:intron: DNA:mutation:exon:p.E924X(mouse) |
ClinVar RGD |
PMID:25741868 PMID:28492532 PMID:8640229 PMID:14671619 PMID:9054656 PMID:23390527 PMID:19179303 PMID:23934996 PMID:21193012 More...
|
RGD:1578350, RGD:11251681, RGD:11251680, RGD:11041609, RGD:11251676, RGD:11251675, RGD:11251674 |
NCBI chr 8:41,653,225...41,896,741
Ensembl chr 8:41,653,220...41,896,741
|
|
G |
CAD |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38827 |
|
NCBI chr 2:27,217,369...27,243,943
Ensembl chr 2:27,217,369...27,243,943
|
|
G |
DHODH |
dihydroorotate dehydrogenase (quinone) |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38827 |
|
NCBI chr16:72,008,744...72,027,659
Ensembl chr16:72,008,588...72,027,664
|
|
G |
EPB42 |
erythrocyte membrane protein band 4.2 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis, Recessive |
ClinVar RGD |
PMID:28492532 PMID:1558976 |
RGD:1598910 |
NCBI chr15:43,197,227...43,225,737
Ensembl chr15:43,197,227...43,221,018
|
|
G |
GPI |
glucose-6-phosphate isomerase |
|
IAGP |
ClinVar Annotator: match by term: Hereditary spherocytosis |
ClinVar |
PMID:25741868 |
|
NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413
|
|
G |
KLF1 |
KLF transcription factor 1 |
|
ISO ISS |
DNA:missense mutation:exon:p.E339D (1065A>T) (human) |
MouseDO RGD |
PMID:20691777 |
RGD:10769342 |
NCBI chr19:12,884,422...12,887,201
Ensembl chr19:12,884,422...12,887,201
|
|
G |
LOC124153154 |
Sharpr-MPRA regulatory region 1462 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,725,651...41,726,294
|
|
G |
LOC126860368 |
BRD4-independent group 4 enhancer GRCh37_chr8:41541049-41542248 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,683,531...41,684,755
|
|
G |
LOC126860369 |
BRD4-independent group 4 enhancer GRCh37_chr8:41570734-41571933 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,713,216...41,714,415
|
|
G |
LOC130000286 |
ATAC-STARR-seq lymphoblastoid active region 27293 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,702,055...41,702,134
|
|
G |
OR10Z1 |
olfactory receptor family 10 subfamily Z member 1 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis, Recessive |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:158,605,268...158,612,514
Ensembl chr 1:158,605,268...158,612,514
|
|
G |
SLC4A1 |
solute carrier family 4 member 1 (Diego blood group) |
|
IAGP EXP |
DNA:duplication:cds: (human) ClinVar Annotator: match by term: Spherocytosis, Dominant CTD Direct Evidence: marker/mechanism mRNA:splicing error:intron:IVS8+1G>T (human) DNA:missense mutations:cds:p.E40K, p.P147S, p.V488M (human) DNA:missense mutation:cds:p.G771D (human) |
ClinVar CTD RGD |
PMID:1378323 PMID:25741868 PMID:28492532 PMID:36231035 PMID:8282779 PMID:9326249 PMID:9207478 PMID:8547122 More...
|
RGD:1599007, RGD:10450510, RGD:10450506, RGD:10450491 |
NCBI chr17:44,248,390...44,268,135
Ensembl chr17:44,248,390...44,268,141
|
|
G |
SPTA1 |
spectrin alpha, erythrocytic 1 |
|
IAGP ISO |
DNA:polymorphisms:introns,exon: ClinVar Annotator: match by term: Spherocytosis, Recessive ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Recessive ClinVar Annotator: match by term: Congenital spherocytosis DNA:deletion:cds: |
ClinVar RGD |
PMID:8941647 PMID:15384986 PMID:24033266 PMID:25741868 PMID:27292444 PMID:28492532 PMID:31038472 PMID:31147440 PMID:31333484 PMID:31723846 PMID:15384986 PMID:11920196 More...
|
RGD:11059521, RGD:11059522 |
NCBI chr 1:158,610,704...158,686,715
Ensembl chr 1:158,610,704...158,686,715
|
|
G |
SPTB |
spectrin beta, erythrocytic |
|
IEP IAGP EXP |
mRNA:decreased expression:erythrocyte: ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant CTD Direct Evidence: marker/mechanism DNA:mutations:cds,splice junction: |
ClinVar CTD RGD |
PMID:8102379 PMID:19538529 PMID:25741868 PMID:28492532 PMID:29396846 PMID:34201899 PMID:19538529 PMID:19538529 More...
|
RGD:11059526, RGD:11059526 |
NCBI chr14:64,746,283...64,879,907
Ensembl chr14:64,746,283...64,879,907
|
|
G |
UMPS |
uridine monophosphate synthetase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38827 |
|
NCBI chr 3:124,730,452...124,749,273
Ensembl chr 3:124,730,433...124,749,273
|
|
|
G |
ADD2 |
adducin 2 |
|
ISS |
OMIM:182900 |
MouseDO |
|
|
NCBI chr 2:70,656,784...70,768,200
Ensembl chr 2:70,607,618...70,768,225
|
|
G |
ANK1 |
ankyrin 1 |
|
IAGP ISS EXP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 1 ClinVar Annotator: match by term: ANK1-related condition | ClinVar Annotator: match by term: Hereditary spherocytosis type 1 ClinVar Annotator: match by term: Spherocytosis, type 1, autosomal recessive OMIM:182900 CTD Direct Evidence: marker/mechanism |
ClinVar MouseDO CTD OMIM |
PMID:1486040 PMID:7883994 PMID:8640229 PMID:9536098 PMID:9590147 PMID:9887280 PMID:11102985 PMID:11167760 PMID:11372755 PMID:11527968 PMID:12899723 PMID:15071790 PMID:16037067 PMID:16199547 PMID:17327413 PMID:17576681 PMID:21099109 PMID:24033266 PMID:25741868 PMID:27292444 PMID:27427187 PMID:28102861 PMID:28492532 PMID:29396846 PMID:29449435 PMID:29572776 PMID:29597199 PMID:30207817 PMID:31016877 PMID:31122244 PMID:31602632 PMID:31669644 PMID:31723846 PMID:31980736 PMID:32436265 PMID:32518793 PMID:32641076 PMID:32702754 PMID:33014018 PMID:33074480 PMID:33116287 PMID:33620149 PMID:33868383 PMID:34335240 PMID:34953813 PMID:36071563 PMID:36598564 PMID:36816036 PMID:38592584 More...
|
|
NCBI chr 8:41,653,225...41,896,741
Ensembl chr 8:41,653,220...41,896,741
|
|
G |
EPB42 |
erythrocyte membrane protein band 4.2 |
|
ISS |
OMIM:182900 |
MouseDO |
|
|
NCBI chr15:43,197,227...43,225,737
Ensembl chr15:43,197,227...43,221,018
|
|
G |
LOC124153154 |
Sharpr-MPRA regulatory region 1462 |
|
IAGP |
ClinVar Annotator: match by term: Spherocytosis, type 1, autosomal recessive ClinVar Annotator: match by term: Hereditary spherocytosis type 1 |
ClinVar |
PMID:8640229 PMID:16037067 PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,725,651...41,726,294
|
|
G |
LOC126860368 |
BRD4-independent group 4 enhancer GRCh37_chr8:41541049-41542248 |
|
IAGP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 1 ClinVar Annotator: match by term: ANK1-related condition | ClinVar Annotator: match by term: Hereditary spherocytosis type 1 |
ClinVar |
PMID:8640229 PMID:12899723 PMID:25741868 PMID:28492532 PMID:33014018 |
|
NCBI chr 8:41,683,531...41,684,755
|
|
G |
LOC126860369 |
BRD4-independent group 4 enhancer GRCh37_chr8:41570734-41571933 |
|
IAGP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 1 |
ClinVar |
PMID:11372755 PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,713,216...41,714,415
|
|
G |
LOC130000286 |
ATAC-STARR-seq lymphoblastoid active region 27293 |
|
IAGP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 1 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 8:41,702,055...41,702,134
|
|
G |
SPTA1 |
spectrin alpha, erythrocytic 1 |
|
ISS |
OMIM:182900 |
MouseDO |
|
|
NCBI chr 1:158,610,704...158,686,715
Ensembl chr 1:158,610,704...158,686,715
|
|
|
G |
PLEKHG3 |
pleckstrin homology and RhoGEF domain containing G3 |
|
IAGP |
ClinVar Annotator: match by term: SPTB-related condition ClinVar Annotator: match by term: Hereditary spherocytosis type 2 |
ClinVar |
PMID:25741868 |
|
NCBI chr14:64,704,424...64,750,249
Ensembl chr14:64,704,102...64,750,249
|
|
G |
SPTB |
spectrin beta, erythrocytic |
|
IAGP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 2 ClinVar Annotator: match by term: Hereditary spherocytosis type 2 | ClinVar Annotator: match by term: SPTB-related condition |
ClinVar OMIM |
PMID:1391962 PMID:1498324 PMID:6426236 PMID:7883966 PMID:8018926 PMID:8667615 PMID:8844207 PMID:9536098 PMID:9714702 PMID:11703334 PMID:17576681 PMID:19538529 PMID:25741868 PMID:26830532 PMID:27292444 PMID:28102861 PMID:28492532 PMID:29572776 PMID:29758562 PMID:30198572 PMID:30486584 PMID:31122244 PMID:31126250 PMID:31602632 PMID:31807509 PMID:32436265 PMID:32641076 PMID:33074480 PMID:36135330 PMID:38592584 More...
|
|
NCBI chr14:64,746,283...64,879,907
Ensembl chr14:64,746,283...64,879,907
|
|
|
G |
OR10Z1 |
olfactory receptor family 10 subfamily Z member 1 |
|
IAGP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 3 |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:158,605,268...158,612,514
Ensembl chr 1:158,605,268...158,612,514
|
|
G |
SPTA1 |
spectrin alpha, erythrocytic 1 |
|
IAGP ISS EXP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 3 OMIM:270970 CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Spherocytosis type 3 ClinVar Annotator: match by term: Spherocytosis, type 3, autosomal recessive |
ClinVar MouseDO CTD OMIM |
PMID:1638030 PMID:3785322 PMID:8081008 PMID:8370581 PMID:8941647 PMID:9192783 PMID:15071791 PMID:15384986 PMID:18815189 PMID:21212007 PMID:23241237 PMID:24033266 PMID:25741868 PMID:26002053 PMID:27292444 PMID:27667160 PMID:27863252 PMID:28492532 PMID:29105823 PMID:29396846 PMID:31038472 PMID:31147440 PMID:31333484 PMID:31602632 PMID:31723846 PMID:31854503 PMID:32266426 PMID:32436265 PMID:32581362 PMID:32888494 PMID:33074880 PMID:33556202 More...
|
|
NCBI chr 1:158,610,704...158,686,715
Ensembl chr 1:158,610,704...158,686,715
|
|
|
G |
SLC4A1 |
solute carrier family 4 member 1 (Diego blood group) |
|
IAGP ISS EXP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 4 ClinVar Annotator: match by term: Hereditary spherocytosis type 4 | ClinVar Annotator: match by term: Spherocytosis type 4 OMIM:612653 CTD Direct Evidence: marker/mechanism |
ClinVar MouseDO CTD |
PMID:893429 PMID:1378323 PMID:1419785 PMID:1520883 PMID:1678289 PMID:1696010 PMID:1722314 PMID:1737855 PMID:2146504 PMID:2196932 PMID:2527366 PMID:6338046 PMID:7530501 PMID:7689982 PMID:7812009 PMID:7919393 PMID:7949112 PMID:8011524 PMID:8206915 PMID:8282779 PMID:8343110 PMID:8434259 PMID:8471774 PMID:8547122 PMID:8567957 PMID:8608262 PMID:8640229 PMID:8704215 PMID:8943874 PMID:9012689 PMID:9207478 PMID:9233560 PMID:9312167 PMID:9565662 PMID:9600966 PMID:9734643 PMID:9854053 PMID:9973643 PMID:10403343 PMID:10580570 PMID:10745622 PMID:10766130 PMID:10926824 PMID:10942416 PMID:11155072 PMID:11208088 PMID:11380459 PMID:12087557 PMID:12750988 PMID:12938018 PMID:14618420 PMID:16107207 PMID:16227998 PMID:16420521 PMID:17215882 PMID:18266205 PMID:19229254 PMID:19289107 PMID:19565014 PMID:19625994 PMID:20068363 PMID:20151848 PMID:20421175 PMID:20799361 PMID:21039340 PMID:22126643 PMID:22518001 PMID:22609520 PMID:23255290 PMID:23842529 PMID:24033266 PMID:24652967 PMID:25111073 PMID:25296721 PMID:25741868 PMID:26571219 PMID:26879370 PMID:27058983 PMID:27292444 PMID:28045035 PMID:28188436 PMID:28233610 PMID:28492532 PMID:28542241 PMID:29572776 PMID:29627839 PMID:29725771 PMID:30192042 PMID:30230413 PMID:31122244 PMID:31126250 PMID:31147440 PMID:31672324 PMID:31959358 PMID:32071839 PMID:32266426 PMID:32641076 PMID:32926342 PMID:33532864 PMID:34093240 PMID:34746046 PMID:35738466 PMID:35845192 PMID:36203343 PMID:36231035 PMID:37353797 More...
|
|
NCBI chr17:44,248,390...44,268,135
Ensembl chr17:44,248,390...44,268,141
|
|
|
G |
EPB42 |
erythrocyte membrane protein band 4.2 |
|
IAGP EXP |
ClinVar Annotator: match by term: Hereditary spherocytosis type 5 CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:1558976 PMID:2386772 PMID:7772513 PMID:7803799 PMID:8319790 PMID:8528207 PMID:8547071 PMID:8635206 PMID:10406914 PMID:12176912 PMID:15692067 PMID:19508687 PMID:25741868 PMID:28492532 PMID:29402830 PMID:32726712 PMID:36203343 More...
|
|
NCBI chr15:43,197,227...43,225,737
Ensembl chr15:43,197,227...43,221,018
|
|
|
G |
CLDN1 |
claudin 1 |
|
IAGP EXP |
DNA:deletion, nonsense mutation:exon:200_201delTT(human) ClinVar Annotator: match by term: Neonatal ichthyosis-sclerosing cholangitis syndrome ClinVar Annotator: match by term: CLDN1-related condition ClinVar Annotator: match by term: CLDN1-related condition | ClinVar Annotator: match by term: Neonatal ichthyosis-sclerosing cholangitis syndrome CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM RGD |
PMID:12164927 PMID:15521008 PMID:16619213 PMID:25741868 PMID:28492532 PMID:15521008 More...
|
RGD:11341732 |
NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
|
|
G |
CLDN16 |
claudin 16 |
|
IAGP |
ClinVar Annotator: match by term: Neonatal ichthyosis-sclerosing cholangitis syndrome ClinVar Annotator: match by term: CLDN1-related condition ClinVar Annotator: match by term: CLDN1-related condition | ClinVar Annotator: match by term: Neonatal ichthyosis-sclerosing cholangitis syndrome |
ClinVar |
PMID:12164927 PMID:15521008 PMID:16619213 PMID:25741868 PMID:28492532 |
|
NCBI chr 3:190,290,361...190,412,138
Ensembl chr 3:190,322,541...190,412,138
|
|
|
G |
APC |
APC regulator of WNT signaling pathway |
|
IAGP |
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma |
ClinVar |
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
|
|
NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239
|
|
G |
ARID1A |
AT-rich interaction domain 1A |
disease_progression exacerbates |
IEP |
mRNA,protein:decreased expression:intrahepatic bile duct (human) |
RGD |
PMID:30849962 PMID:27433094 PMID:31665232 |
RGD:14974231, RGD:126775257, RGD:126781775 |
NCBI chr 1:26,696,015...26,782,104
Ensembl chr 1:26,693,236...26,782,104
|
|
G |
BAP1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
IEP |
|
RGD |
PMID:27864835 |
RGD:150340628 |
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
|
|
G |
BECN1 |
beclin 1 |
disease_progression |
IEP |
|
RGD |
PMID:30849962 |
RGD:14974231 |
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
severity |
IAGP |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:24139215 |
RGD:14398746 |
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
FAS |
Fas cell surface death receptor |
disease_progression |
IEP |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
severity |
IEP |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FOXP3 |
forkhead box P3 |
|
ISO |
DNA:hypomethylation:liver |
RGD |
PMID:24291052 |
RGD:38599002 |
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
disease_progression |
IEP |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSP90AB1 |
heat shock protein 90 alpha family class B member 1 |
disease_progression |
IEP |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
|
|
G |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
no_association |
IAGP |
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human) |
RGD |
PMID:26245674 |
RGD:14974229 |
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
|
|
G |
IDH2 |
isocitrate dehydrogenase (NADP(+)) 2 |
disease_progression |
IAGP ISO |
DNA:mutations: : mRNA:decreased expression:liver (mouse) |
RGD |
PMID:22824796 PMID:32463951 |
RGD:14985256, RGD:149735894 |
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
|
|
G |
KDM5C |
lysine demethylase 5C |
exacerbates |
HEP |
protein:decreased expression:bile duct (human) |
RGD |
PMID:32714863 |
RGD:151361175 |
NCBI chr X:53,176,277...53,225,207
Ensembl chr X:53,176,277...53,225,422
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
disease_progression |
ISS IAGP |
DNA:mutations:: |
MouseDO RGD |
PMID:24139215 |
RGD:14398746 |
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
LCN2 |
lipocalin 2 |
treatment |
ISO IEP |
Protein:increased expression:bile duct |
RGD |
PMID:24939880 PMID:24939880 |
RGD:126790491, RGD:126790491 |
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
LRP1B |
LDL receptor related protein 1B |
exacerbates |
IAGP |
DNA:mutations:multiple: (human) |
RGD |
PMID:33014052 |
RGD:150429786 |
NCBI chr 2:140,231,423...142,131,016
Ensembl chr 2:140,231,423...142,131,016
|
|
G |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
disease_progression |
HEP |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
|
|
G |
MIR152 |
microRNA 152 |
|
IEP |
miRNA:decreased expression:intrahepatic bile duct |
RGD |
PMID:28921383 |
RGD:19165148 |
NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247
|
|
G |
MIR200B |
microRNA 200b |
|
IEP |
RNA:increased expression:liver |
RGD |
PMID:27685844 |
RGD:14928335 |
NCBI chr 1:1,167,104...1,167,198
Ensembl chr 1:1,167,104...1,167,198
|
|
G |
MIR21 |
microRNA 21 |
|
IEP |
RNA:increased expression:liver,plasma |
RGD |
PMID:27685844 |
RGD:14928335 |
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR221 |
microRNA 221 |
severity |
IEP |
|
RGD |
PMID:27685844 |
RGD:14928335 |
NCBI chr X:45,746,157...45,746,266
Ensembl chr X:45,746,157...45,746,266
|
|
G |
PBRM1 |
polybromo 1 |
disease_progression |
IEP HEP |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:27864835 PMID:30377796 |
RGD:150340628, RGD:152998946 |
NCBI chr 3:52,545,367...52,685,913
Ensembl chr 3:52,545,352...52,685,917
|
|
G |
PTEN |
phosphatase and tensin homolog |
disease_progression |
IEP |
protein:decreased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
RNF43 |
ring finger protein 43 |
exacerbates |
IEP |
mRNA, protein:decreased expression:liver, bile duct epithelium (human) |
RGD |
PMID:26980022 |
RGD:151361125 |
NCBI chr17:58,352,500...58,417,534
Ensembl chr17:58,353,676...58,417,595
|
|
G |
RUNX1 |
RUNX family transcription factor 1 |
|
IEP |
mRNA:increased expression:intrahepatic bile duct |
RGD |
PMID:31015363 |
RGD:126775143 |
NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
|
|
G |
S100B |
S100 calcium binding protein B |
disease_progression |
HEP |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
|
|
G |
SMAD4 |
SMAD family member 4 |
disease_progression |
IEP |
mRNA,protein:decreased expression:intrahepatic bile duct |
RGD |
PMID:16917866 PMID:23981608 |
RGD:18936999, RGD:21066336 |
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
|
|
G |
TEP1 |
telomerase associated protein 1 |
|
IEP |
mRNA:increased expression:hepatocyte,biliary epithelium. |
RGD |
PMID:10498642 |
RGD:152977753 |
NCBI chr14:20,365,667...20,413,501
Ensembl chr14:20,365,667...20,413,501
|
|
G |
TERC |
telomerase RNA component |
|
IEP |
RNA:increased expression:hepatocyte,biliary epithelium. |
RGD |
PMID:10498642 |
RGD:152977753 |
NCBI chr 3:169,764,610...169,765,060
Ensembl chr 3:169,764,610...169,765,047 Ensembl chr 3:169,764,610...169,765,047
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
susceptibility |
IAGP ISO EXP |
ClinVar Annotator: match by term: Progressive intrahepatic cholestasis CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:9806540 PMID:10579978 PMID:12370274 PMID:12717091 PMID:15300568 PMID:16039748 PMID:16290310 PMID:16641580 PMID:16871584 PMID:17855769 PMID:18049162 PMID:18395098 PMID:18692205 PMID:19101985 PMID:19750581 PMID:19845854 PMID:20232290 PMID:20414253 PMID:20583290 PMID:20683201 PMID:21404481 PMID:21490445 PMID:22364601 PMID:24231640 PMID:24339557 PMID:24402531 PMID:24627769 PMID:25741868 PMID:26382629 PMID:26678486 PMID:26858187 PMID:27050426 PMID:27114171 PMID:27239116 PMID:27426735 PMID:28027573 PMID:28119944 PMID:28492532 PMID:28733223 PMID:29104077 PMID:29412511 PMID:30210030 PMID:31745229 PMID:32087350 PMID:32309332 PMID:32581362 PMID:32808743 PMID:32860008 PMID:33215027 PMID:33915153 PMID:34016879 PMID:35257483 PMID:9806540 PMID:22619174 More...
|
RGD:1598583, RGD:14688049 |
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
treatment |
ISO IAGP IDA ISS |
ClinVar Annotator: match by term: Progressive intrahepatic cholestasis DNA:mutation:exon:c.2362C>T (p.Arg788Trp)(human) OMIM:147480 | OMIM:211600 | OMIM:243300 | OMIM:601847 | OMIM:602347 | OMIM:605479 | OMIM:614972 | OMIM:615878 |
ClinVar MouseDO RGD |
PMID:11313316 PMID:12891548 PMID:15077010 PMID:16199547 PMID:16890614 PMID:17726488 PMID:19467940 PMID:19490418 PMID:19584064 PMID:19840255 PMID:20422496 PMID:20537830 PMID:21119540 PMID:22331132 PMID:22527017 PMID:23022423 PMID:23533021 PMID:24033266 PMID:24381502 PMID:24806754 PMID:25741868 PMID:25755532 PMID:26126923 PMID:26153658 PMID:26256905 PMID:26324191 PMID:26474921 PMID:26699824 PMID:28039895 PMID:28492532 PMID:28587926 PMID:28776642 PMID:28924228 PMID:29761167 PMID:30036524 PMID:30449124 PMID:31130284 PMID:31181191 PMID:31538484 PMID:31625567 PMID:31728073 PMID:32581362 PMID:32626542 PMID:32893960 PMID:32917322 PMID:33915153 PMID:34016879 PMID:34376370 PMID:34678161 PMID:35626323 PMID:35894240 PMID:35905201 PMID:8106172 PMID:30935993 PMID:18781607 More...
|
RGD:1300325, RGD:14695045, RGD:14695044 |
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
AP1S1 |
adaptor related protein complex 1 subunit sigma 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23423674 |
|
NCBI chr 7:101,154,476...101,161,276
Ensembl chr 7:101,154,456...101,161,596
|
|
G |
ATP8B1 |
ATPase phospholipid transporting 8B1 |
susceptibility |
IAGP EXP |
DNA:mutation ClinVar Annotator: match by term: Progressive intrahepatic cholestasis CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:5807632 PMID:9500542 PMID:9918928 PMID:11815775 PMID:14988830 PMID:15239083 PMID:18379143 PMID:19260995 PMID:19731236 PMID:19918981 PMID:20232290 PMID:20414253 PMID:22525741 PMID:25741868 PMID:26382629 PMID:26678486 PMID:26858187 PMID:26879107 PMID:28492532 PMID:28733223 PMID:30366773 PMID:31450232 PMID:33437900 PMID:33666275 PMID:34016879 PMID:9500542 More...
|
RGD:1599397 |
NCBI chr18:57,646,426...57,803,315
Ensembl chr18:57,646,426...57,803,315
|
|
G |
ATP8B1-AS1 |
ATP8B1 antisense RNA 1 |
|
IAGP |
ClinVar Annotator: match by term: Progressive intrahepatic cholestasis |
ClinVar |
PMID:9500542 PMID:15239083 PMID:25741868 PMID:28492532 PMID:28733223 PMID:33666275 PMID:34016879 More...
|
|
NCBI chr18:57,630,331...57,669,283
Ensembl chr18:57,629,870...57,738,678
| |